year
later
late
valid
jenner
approach
combat
smallpox
reaffirm
pasteur
succeed
select
avirul
strain
rabi
viru
use
vaccin
time
studi
iwanowski
beijerinck
began
reveal
natur
unknown
form
infecti
agent
plant
somewhat
later
similar
revel
emerg
studi
loeffler
frosch
infect
cattl
ubiqu
kind
agent
reveal
studi
twort
dherrel
show
bacteria
suscept
becam
known
filter
virus
knowledg
exist
natur
virus
accru
knowledg
exist
natur
antibodi
studi
von
behr
kitasato
bordet
n
sternberg
see
hahon
infer
blood
individu
recent
recov
infect
smallpox
contain
antitoxin
would
neutral
activ
poison
diseas
infer
prove
correct
show
serum
recent
vaccin
calf
neural
cowpox
viru
observ
presag
start
experiment
viral
immunolog
rel
eas
simplic
cultiv
bacteri
virus
led
earli
highli
product
studi
interact
antibodi
introduct
woodruff
goodpastur
use
embryon
chick
egg
anim
viru
host
greatli
stimul
research
anim
virus
use
host
extend
burnet
develop
techniqu
infect
cliorioallanto
membran
manner
result
discret
lesion
pock
could
readili
recogn
enumer
applic
plaqu
assay
bacteri
virus
pockcount
assay
anim
virus
era
quantit
virolog
incept
variou
aspect
interact
bacteri
virus
antibodi
studi
andrew
elford
england
similar
studi
well
studi
anim
virus
carri
australia
burnet
colleagu
one
result
extens
studi
summar
great
detail
burnet
et
al
conclus
respect
interact
antibodi
bacteri
anim
virus
basic
differ
specif
differ
resid
stabil
union
viru
antibodi
wherea
bacteri
virus
form
stabl
complex
anim
virus
form
complex
tend
dissoci
readili
introduct
anim
cell
cultur
host
system
greatli
aid
studi
anim
virus
respect
fewer
readili
control
variabl
use
plaqu
assay
enhanc
quantit
reliabl
dulbecco
et
al
describ
interact
two
anim
virus
respect
antibodi
result
studi
led
investig
conclud
among
thing
anim
virus
least
two
studi
react
antibodi
form
complex
dissoci
spontan
interpret
challeng
fazeka
de
st
groth
reid
anim
virusantibodi
system
studi
mani
investig
seem
greater
accord
irrevers
rather
revers
interact
reason
articl
assum
differ
bacteri
virus
one
categori
anim
virus
separ
categori
concern
interact
antibodi
rather
differ
exist
consid
relat
virus
per
se
although
articl
intend
survey
neutral
anim
virus
occasion
refer
made
studi
bacteri
virus
studi
pertin
illumin
topic
hand
subject
review
great
detail
fazeka
de
st
groth
wherev
feasibl
relationship
reduc
mathemat
term
subsequ
review
present
svehag
svehag
emphasi
biochem
aspect
virusantibodi
interact
role
antibodi
divers
interact
notkin
majer
review
topic
viral
sensit
antibodi
ie
format
virusantibodi
complex
continu
infecti
acquir
sensit
reagent
complement
antibodi
specif
antibodi
bound
viru
recent
topic
survey
also
review
subject
immunopatholog
relat
virusinduc
immunocomplex
aspect
gener
subject
viral
immunolog
review
cowan
describ
characterist
immun
respons
viral
antigen
burn
allison
discuss
immun
respons
mechan
neutral
natur
cellmedi
immun
method
studi
virusantibodi
complex
review
mandel
particular
relev
review
daniel
dellaporta
westaway
deal
variou
aspect
mechan
underli
neutral
reaction
studi
vitro
interact
virus
antibodi
includ
wide
array
anim
bacteri
virus
antibodi
deriv
varieti
anim
speci
n
instanc
antibodi
obtain
anim
respond
activ
infect
n
instanc
nonsuscept
anim
induc
synthes
antibodi
inocul
viral
immunogen
latter
instanc
rabbit
use
frequent
indic
section
ii
c
l
antibodi
divers
group
molecular
speci
vari
physicochem
well
function
variou
studi
vitro
reaction
viru
antibodi
knowledg
specif
type
antibodi
alway
avail
suffici
detail
provid
condit
antibodi
ie
serum
obtain
report
petti
steward
use
adjuv
enhanc
immun
respons
may
affect
level
qualiti
antibodi
accord
composit
adjuv
nonetheless
gener
characterist
vitro
reaction
found
reason
consist
warrant
gener
concentr
viru
antibodi
appropri
adjust
rate
reaction
ie
loss
infect
measur
quantit
express
rate
base
earli
part
reaction
mathemat
describ
equat
firstord
reaction
ct
co
concentr
time
zero
respect
k
constant
adapt
use
measur
neutral
equat
becom
adam
v
v
respect
concentr
viru
frequent
minut
final
dilut
serum
constant
le
rate
constant
minl
inform
avail
term
replac
known
molar
concentr
antibodi
case
k
dimens
minl
molel
effect
sever
environment
condit
reaction
viru
antibodi
studi
procedur
quit
straightforward
involv
measur
rate
constant
specifi
condit
variou
studi
cover
rang
temperatur
consist
stabil
reactant
indic
reaction
activ
temperatur
activ
energi
order
kcalmol
report
anim
bacteri
virus
interpret
chang
rate
depend
thermal
diffus
reactant
effici
interact
unaffect
concentr
salt
consider
influenc
exampl
jern
skovst
report
salt
concentr
reduccd
rate
increas
other
svehag
walli
et
al
report
similar
find
order
magnitud
quit
like
shown
svehag
degre
salt
effect
vari
qualiti
associ
affin
antibodi
walli
et
al
state
salt
effect
seen
igg
igm
antibodi
antiserum
baboon
rabbit
sheep
show
effect
although
highli
depend
optimum
ph
reaction
becom
decreasingli
effici
either
extrem
undoubtedli
reflect
decreas
number
reactiv
complementari
ionic
group
due
titrat
low
high
ph
shown
restor
ph
neutral
restor
reactiv
viru
antibodi
henc
reduc
rate
ph
extrem
consequ
denatur
bind
antibodi
molecul
antigen
site
viru
mediat
noncoval
interact
shortrang
interact
hydrogen
bond
electrostat
interact
van
der
waal
forc
possibl
nonpolar
hydrophob
reaction
thermodynam
studi
indic
forward
reaction
accompani
increas
entropi
chang
mean
free
energi
order
kcalmol
reaction
therefor
downhil
ie
entropydriven
studi
effect
temperatur
reaction
rate
indic
system
subject
activ
rate
chang
observ
relat
simpli
chang
collis
frequenc
induc
chang
thermal
diffus
reaction
rate
order
mole
sec
report
sever
system
indic
rapid
process
hornick
karush
suggest
ratelimit
variabl
collis
effici
rather
collis
frequenc
success
collis
requir
reactiv
site
apposit
time
approach
indic
function
bind
affin
virusantibodi
interact
examin
effect
valenc
extrem
import
karush
studi
bacteriophag
increas
lo
bival
compar
monoval
bind
blank
et
al
similarli
stress
aspect
view
fact
virusantibodi
interact
involv
bival
antibodi
multival
viral
particl
like
major
virusantibodi
complex
character
monogam
bival
union
henc
high
bind
affin
although
tendenc
may
focu
interact
viru
antibodi
heart
reaction
becom
clear
host
cell
must
scrutin
reason
twofold
outcom
given
reaction
may
vari
host
cell
host
anim
sinc
virus
inert
antibodi
inhibit
viral
function
adsorpt
behavior
therefor
instanc
neutral
viru
adsorb
failur
infect
due
inabl
cell
react
viru
would
unneutr
particl
divers
antibodi
serum
anim
given
time
function
sever
sourc
variabl
differ
class
subclass
antibodi
exist
vari
physicochem
well
function
characterist
class
antibodi
produc
may
depend
mass
immunogen
shown
svehag
mandel
rel
low
amount
polioviru
class
antibodi
induc
rabbit
highcr
amount
antibodi
arc
elicit
shown
mani
instanc
qualiti
ie
effect
antibodi
improv
increas
time
immun
respons
characterist
impli
matur
proccss
reflect
progress
either
continu
discret
improv
combin
characterist
antibodi
viral
immunogcn
one
determin
induc
antibodi
one
interact
unfraction
serum
respect
viru
expect
involv
complex
set
interact
involv
refipect
antibodyantigen
system
well
possibl
influenc
among
differ
system
due
steric
complic
technic
aspect
immun
procedur
dose
immunogen
rout
inocul
frequenc
inocul
use
adjuvantsinflu
time
cours
class
antibodi
respond
immun
report
earlier
literatur
eg
burnet
et
al
outcom
neutral
reaction
absolut
may
regist
posit
neg
result
depend
host
cell
anim
use
indic
import
sourc
variat
reemphas
recent
result
describ
kjellh
schlesing
subsequ
investig
may
import
consider
sinc
natur
neutral
phenomenon
may
alter
viral
capsid
lesser
greater
subtleti
alter
may
one
cell
repres
qualit
unrecogniz
particl
anoth
alter
particl
albeit
one
cell
still
recogn
cope
perhap
ineffici
andrew
elford
exampl
discuss
basi
abnorm
small
plaqu
term
incomplet
neutral
viru
also
shown
rate
appear
delay
survivor
anim
viru
neutral
assay
mandel
westaway
yoshino
taniguchi
unusu
host
variat
describ
hawk
antiserum
togavirus
enhanc
infect
provid
antiserum
obtain
fowl
rabbit
mice
host
chick
cell
pig
kidney
cell
enhanc
result
interact
low
concentr
serum
neutral
observ
higher
concentr
subsequ
studi
hawk
lafferti
suggest
enhanc
result
modif
protein
capsid
render
viru
effici
interact
chick
cell
three
aspect
relevancecomplex
stabil
origin
viral
antigen
respect
stabil
genotyp
virus
usual
stabl
one
assur
given
viru
display
antigen
characterist
time
irrespect
host
replic
envelop
virus
situat
complic
fact
antigen
deriv
two
sourc
stabl
viruscod
protein
hostcod
lipoprotein
compris
envelop
thoroughli
establish
viral
envelop
acquir
host
cell
matur
eg
hauken
although
envelop
contain
viral
protein
also
retain
antigen
characterist
host
consequ
virus
induc
react
two
group
antibodi
differ
specif
nonenvelop
virus
may
simpl
complex
rna
bacteriophag
exampl
construct
one
kind
polypeptid
one
molecul
protein
may
irrelev
although
picornavirus
contain
four
polypeptid
certain
member
polioviru
rhinoviru
induc
synthesi
one
specif
antibodi
probabl
morpholog
unit
function
immunogen
element
increas
complex
number
determin
increas
interpret
effect
antibodi
virus
becom
difficult
sinc
distinct
requir
among
critic
noncrit
possibili
quasicrit
site
illustr
madeley
et
al
show
hemagglutinin
neuraminidas
antigen
influenza
viru
induc
specif
antibodi
antihemagglutinin
antibodi
neutral
infect
antineuraminidas
antibodi
effect
report
antibodi
interfer
suggest
antigen
structur
arrang
steric
interfer
majer
link
similarli
observ
specif
antibodi
respons
addit
show
nonneutr
interact
neuraminidas
antibodi
could
lead
neutral
addit
antiglobulin
serum
reason
explan
opinion
worker
steric
interfer
hemagglutinin
antigen
follow
secondari
antibodi
reaction
virus
complex
aggrav
adenoviru
three
protein
antigen
hexon
penton
fiber
elicit
specif
antibodi
strain
hexon
antibodi
neutral
consequ
howev
shown
interact
rather
complic
kjellbn
pereira
hexon
consist
two
antigen
one
subsurfac
interact
antibodi
surfac
antigen
result
rearrang
hexon
structur
expos
second
antigen
neutral
consequ
reaction
antigen
antibodi
recent
symington
et
al
studi
effect
antisera
prepar
specif
two
el
surfac
glycoprotein
sindbi
viru
antiserum
alon
poor
neutral
activ
antiserum
versu
intact
virion
howev
activ
two
specif
sera
separ
conjunct
brown
smale
describ
complex
interact
fmd
viru
picornaviru
viral
antiserum
suggest
three
distinct
antigen
bind
site
two
associ
vertex
region
third
planar
surfac
specif
respect
interact
igg
igm
respect
combin
site
sinc
studi
base
agar
precipitin
reaction
electron
microscopi
signific
interact
assess
respect
neutral
subsequ
studi
rowland
et
al
reveal
antigen
locat
vertex
involv
stimul
product
neutral
antibodi
recent
cavanagh
et
al
report
vp
capsid
polypeptid
fmd
viru
induc
neutral
antibodi
studi
anoth
picornaviru
polioviru
show
antigen
specif
relat
structur
requir
subvir
particl
specif
parent
particl
howev
substructur
particl
antigen
distinct
protein
antibodi
activ
encompass
divers
group
molecular
speci
vari
sever
paramet
mw
net
surfac
charg
conform
number
antigenbind
site
valenc
propens
react
antigen
avid
forc
bind
antigen
afhiti
numer
domin
class
antibodi
igg
form
compos
two
heavi
h
two
light
l
polypeptid
chain
bound
interchain
disulfid
linkag
two
antigenbind
site
locat
termini
two
pair
lh
chain
molecul
dissect
enzym
obtain
specif
fragment
pepsin
cleav
molecul
fragment
contain
combin
site
lack
portion
h
chain
fragment
design
f
ab
dissoci
reduc
condit
two
monoval
fragment
design
fab
papain
cleav
molecul
two
monoval
fragment
design
fab
one
fragment
design
fc
antibodi
activ
third
method
dissect
molecul
base
reduct
interpeptid
disulfid
bond
yield
free
l
h
chain
differ
class
antibodi
vari
valenc
bi
tetra
decaval
accordingli
mw
froin
soo
ooo
dalton
comprehens
discuss
subject
reader
refer
spiegelberg
review
function
variou
segment
antibodi
molecul
neutral
reaction
studi
isol
desir
fragment
examin
behavior
vogt
et
al
demonstr
fab
fragment
polioviru
antibodi
retain
neutral
activ
reduc
effici
comparison
fab
fragment
nativ
antibodi
kinet
analysi
show
reduc
reaction
rate
monoval
fab
fragment
vogt
et
al
also
state
virusfab
complex
stabl
subject
dilut
although
kinet
reaction
observ
long
enough
sure
data
indic
eventu
reaction
approach
final
level
although
differ
rate
cremer
et
al
report
polioviru
wee
viru
neutral
fab
fragment
respect
antibodi
result
obtain
metabol
inhibit
test
howev
neutral
wee
viru
evalu
mous
infect
evid
neutral
worker
consid
possibl
dissoci
occur
fc
moieti
molecul
requir
philipson
et
al
developecl
interest
system
detect
virusantibodi
interact
base
distribut
viru
two
phase
aqueou
polym
system
polioviru
neutral
intact
antibodi
distribut
pattern
invert
howev
viru
neutral
fab
fragment
distribut
pattern
remain
characterist
unneutr
viru
philipson
bennich
also
report
viru
neutral
partial
separ
otherwis
intact
igg
molecul
result
reduct
alkyl
show
distribut
pattern
intermedi
viru
neutral
nativ
igg
viru
neutral
fab
result
suggest
distribut
pattern
virusantibodi
complex
relat
charg
characterist
viru
antibodi
antibodi
fragment
speci
complex
may
undergo
modif
consequ
interact
neutral
reaction
polioviru
igg
f
fab
compar
keller
neutral
similar
three
form
antibodi
stabil
virusantibodi
complex
howev
vari
examin
dilut
dissoci
acid
reactiv
shortli
format
complex
antibodi
least
stabl
antibodi
stabl
given
suffici
time
complex
approach
uniform
state
stabil
inasmuch
antibodi
bival
keller
consid
likelihood
fc
fragment
contribut
stabil
virusantibodi
complex
light
report
subsequ
articl
keller
puzzl
polioviru
neutral
antibodi
exposur
virusantibodi
complex
pepsin
convert
molecul
form
without
chang
neutral
statu
viru
treatment
reduc
agent
convert
bival
molecul
monoval
form
restor
infect
antibodi
fragment
still
associ
viru
shown
sensit
complex
antibodi
specif
attach
fragment
keller
previous
report
fragment
neutral
activ
studi
effect
neutral
antibodi
polioviru
mandel
seen
neutral
accompani
chang
electrophoret
characterist
viru
analysi
phenomenon
mandel
show
fab
fragment
effect
nativ
antibodi
name
neutral
electrophoret
modif
interact
adenoviru
monoval
antibodi
fragment
examin
kjellcn
although
fragment
inhibit
hemagglutin
reduct
infect
antibodi
fragment
shown
bound
viru
block
experi
possibl
kjellcn
conjectur
fc
portion
essenti
neutral
fragment
react
site
critic
latter
possibl
pose
question
block
action
neutral
antibodi
studi
influenza
viru
lafferti
report
fab
fragment
neutral
infect
inhibit
hemagglutin
howev
contrast
antibodi
virusmonoval
antibodi
complex
acquir
stabil
lafferti
attribut
defici
antibodi
monoval
neutral
herpesviru
fab
fragment
report
ash
et
al
also
shown
fab
fragment
antiantibodi
neutral
herpesviru
sensit
viral
fab
antibodi
shinkai
yoshino
examin
reactiv
antibodi
fragment
toward
herpesviru
week
initi
immun
respons
f
ab
neutral
poorli
week
neutral
capabl
equal
igg
week
monoval
fab
fragment
fail
neutral
per
se
well
presenc
antiantibodi
evid
fragment
combin
viru
provid
block
experi
week
immun
respons
fab
display
moder
neutral
capac
could
enhanc
antiantibodi
sever
investig
interact
bacteri
virus
antibodi
fragment
report
klinman
et
al
use
fragment
evalu
role
antibodi
valenc
neutral
rna
bacteriophag
comparison
neutral
rate
constant
bival
molecul
monoval
molecul
reveal
higher
rate
bival
molecul
monoval
antibodi
hybrid
molecul
contain
one
reactiv
site
result
stress
contribut
valenc
minim
role
fc
portion
antibodi
molecul
investig
attribut
specul
lower
reaction
rate
monoval
antibodi
lower
bind
afkiti
concomit
higher
dissoci
rate
compar
bival
antibodi
rowland
question
role
antibodi
size
steric
effect
neutral
effici
neutral
rate
constant
moleculel
ml
minl
antibodi
determin
use
bacteriophag
close
relat
molecul
rate
constant
x
x
x
lo
respect
sinc
consider
disproportion
rate
constant
molecular
size
conclud
size
rel
minor
determin
effici
neutral
n
studi
neutral
two
coliphag
goodman
donch
observ
effici
decreas
size
valenc
reduc
go
molecul
n
later
studi
goodman
donch
analyz
role
molecular
size
neutral
examin
neutral
abil
l
h
chain
fd
fragment
hchain
portion
compris
antigenbind
region
antibodi
molecul
neither
l
h
fd
fragment
neutral
bacteriophag
howev
bind
viru
occur
sinc
neutral
result
antibodi
specif
respect
fragment
ad
virusfrag
complex
worker
propos
lack
neutral
activ
relat
insuffici
larg
fragment
size
stemk
lennox
compar
neutral
rate
two
coliphag
bival
monoval
antibodi
bival
antibodi
rate
greater
fsb
fragment
greater
fab
fragment
report
interest
observ
wherea
interact
phage
singlehit
antibodi
multihit
averag
hit
fab
fragment
howev
reaction
phage
singlehit
form
reaction
enhanc
addit
antibodi
direct
viral
antibodi
observ
degre
enhanc
invers
relat
neutral
effici
stemk
lennox
propos
sever
paramet
size
valenc
bind
affin
separ
conjunct
contribut
activ
antibodi
also
question
signific
use
antiantibodi
perhap
suggest
neutral
requir
secondari
effect
antiantibodi
bona
fide
interact
respect
either
antibodi
per
se
viral
site
bind
stemk
corrobor
greater
import
valenc
size
antibodi
molecul
blank
et
evalu
rel
influenc
antibodi
valenc
affin
neutral
reaction
base
studi
interact
bacteriophag
coupl
hapten
dnp
rabbit
antidnp
antibodi
conclud
valenc
greater
signific
bival
antibodi
found
least
effici
monoval
antibodi
sinc
forward
reaction
extrem
rapid
investig
consid
neutral
rate
reflect
rate
dissoci
virusantibodi
complex
hornick
karush
studi
neutral
bacteriophag
among
observ
report
bival
antibodi
much
effici
lo
monoval
antibodi
stress
import
valenc
survey
literatur
review
literatur
indic
sever
differ
phenomena
gener
group
viral
neutral
justif
found
fact
measur
consist
among
insofar
viru
antibodi
host
indic
instanc
part
phenomenon
criterion
loss
infect
closer
examin
indic
underli
interact
import
differ
awar
consider
reflect
use
plural
form
daniel
burn
allison
refer
mechan
neutral
discuss
shown
neutral
may
requir
contribut
mediat
eg
complement
may
depend
secondari
phenomena
aggreg
format
may
therefor
use
purpos
analyz
reaction
mechan
defin
variou
situat
primari
simplest
level
virion
compos
multipl
copi
singl
antigen
neutral
one
molecul
singl
molecular
speci
antibodi
interact
independ
thirdparti
mediat
secondari
event
aggreg
possibl
format
virusantibodi
complex
initi
stage
sequenti
rearrang
within
complex
howev
recogn
segment
singl
event
possibl
neutral
state
condit
name
depend
host
unavoid
possibl
explic
inform
complic
b
mediat
primari
reaction
fail
go
complet
may
activ
interact
bound
antibodi
complement
interact
antibodi
c
biphas
two
antigenantibodi
reaction
involv
first
reaction
enabl
second
reaction
take
place
culmin
neutral
steric
hindranc
involv
critic
antigen
occur
virion
neutral
interact
noncrit
antigen
antibodi
result
amass
antibodi
interfer
possibl
prevent
adsorpt
viral
replic
b
virolysi
interact
envelop
virus
envelopespecif
antibodi
also
hostspecif
presenc
complet
complement
system
result
irrevers
traumat
envelop
sinc
virus
also
neutral
antibodi
specif
viruscod
antigen
virolysi
repres
altern
neutral
pathway
sinc
virus
multival
antibodi
bival
possibl
induc
aggreg
format
appropri
adjust
concentr
reactant
interact
antibodi
noncrit
site
lead
neutral
howev
concentr
equival
secondari
event
occur
result
format
lattic
structur
reduct
infect
may
follow
simpli
result
polymer
sever
monomer
unit
singl
infecti
unit
one
conclus
burnet
et
nl
arriv
studi
sever
bacteri
anim
virus
two
group
differ
fundament
interact
antibodi
wherea
bacteri
virus
form
irrevers
complex
neutral
antibodi
anim
virus
examin
burnet
et
al
form
freeli
revers
complex
burnet
assay
inethod
employ
least
formal
compar
name
plaqu
method
bacteriophag
newli
develop
pockcount
method
util
chorioallanto
membran
embryon
chick
egg
anim
virus
subsequ
studi
dulbecco
et
az
two
anim
virus
polioviru
wee
viru
employ
plaqu
assay
method
anim
cell
cultur
indic
reaction
virus
antibodi
irrevers
revers
present
context
repres
dynam
equilibrium
reactant
product
final
equilibrium
depend
upon
associ
dissoci
rate
turn
concentrationdepend
demonstr
revers
requir
sole
variat
reaction
condit
chang
concentr
reaction
compon
usual
dilut
chang
drive
reaction
toward
dissoci
reestablish
equilibrium
characterist
particular
system
aspect
viral
neutral
examin
time
neutral
first
subject
experiment
scrutini
interpret
earli
studi
indic
revers
characterist
neutral
fowl
plagu
viru
todd
vaccinia
viru
andrew
olitski
eee
viru
pierc
et
al
papilloma
viru
bryan
beard
influenza
viru
taylor
burnet
burnet
polioviru
gebhardt
bullock
howev
reaction
consid
irrevers
papilloma
viru
friedewald
kidd
eee
viru
labzoffski
partial
revers
influenza
viru
taylor
burnet
also
report
extent
dilut
dissoci
decreas
prolong
incub
andrew
burnet
aspect
viral
neutral
examin
gard
use
particularli
appropri
system
name
strain
theiler
viru
fa
strain
mous
poliomyel
could
assay
mice
without
dilut
base
incub
period
observ
wherea
undilut
virusserum
mixtur
indic
neutral
dilut
mixtur
howev
hour
day
c
dilut
reaction
mixtur
show
expect
decreas
nondissoci
complex
gard
propos
interact
viru
antibodi
entail
two
stagesa
rapid
weakli
cohes
union
follow
enhanc
forc
bind
viru
antibodi
may
relev
sourc
antibodi
studi
serum
normal
mice
shown
olitski
normal
mice
almost
univers
carri
strain
theiler
viru
antibodi
sera
mice
tospecif
extent
crossreact
two
strain
may
contribut
factor
phenomenon
gard
call
immunoinactiv
howev
subsequ
studi
human
polioviru
homolog
antibodi
gard
observ
immunoinactiv
characterist
use
plaqu
assay
anim
virus
employ
anim
cell
cultur
dulbecco
et
analyz
reaction
wee
viru
polioviru
antibodi
respect
dilut
dissoci
report
phenomenon
occur
virus
studi
revers
virus
employ
cell
cultur
test
system
indic
spontan
dissoci
ndv
rubin
rubin
franklin
granoff
polioviru
mandel
mandel
ketler
et
al
keller
walli
et
al
adenoviru
kjellh
visna
viru
thormar
herpesviru
yoshino
taniguchi
ash
notkin
vee
viru
hahon
possibl
dissoci
occur
minor
degre
consid
jev
hashimoto
princ
iwasaki
ogura
propos
herpesviru
ide
yoshino
w
n
viru
westaway
data
dulbecco
et
al
conclud
reaction
irrevers
reinterpret
fazeka
de
st
groth
reid
show
result
consist
reaction
freeli
revers
subject
massact
phenomena
reaffirm
view
freeli
revers
equilibrium
character
virusantibodi
interact
result
studi
neutral
influenza
viru
fazeka
de
st
groth
webster
complex
neutral
phenomenon
stress
burnet
p
dulbecco
et
al
fazeka
de
st
groth
reid
fazeka
de
st
groth
clear
neutral
consist
three
domainsviru
antibodi
assay
h
n
domain
divid
subdomain
vari
characterist
illustr
svehag
compar
dissoci
poliovirusrabbit
antibodi
complex
antibodi
either
earli
late
neither
case
dissoci
evid
simpl
dilut
dilut
carri
conjunct
increas
ionic
strength
minor
signific
dissoci
occur
viru
complex
antibodi
antibodi
dissoci
occur
salt
molar
increas
bond
strength
complex
function
antibodi
type
result
svehag
indic
late
antibodi
affin
constant
exceedingli
high
studi
polioviru
mandel
shown
centrifug
neutral
viru
suspend
antibodyfre
medium
evid
revers
obtain
period
day
dilut
undilut
resuspend
viru
monitor
neutral
viru
prepar
use
vari
antiserum
multipl
result
surviv
fraction
high
potenti
dissoci
virusantibodi
coinplex
demonstr
acid
reactiv
infect
analysi
dissoci
molecular
level
describ
lafferti
bl
reaction
influenza
viru
antibodi
biphas
respect
time
shortli
initi
reaction
virusantibodi
complex
complet
revers
dilut
given
suffici
time
howev
complex
becam
irrevers
monoval
antibodi
fragment
use
virusantibodi
complex
form
fail
becom
irrevers
lafferti
b
propos
transit
irrevers
repres
time
requir
second
combin
valenc
bound
antibodi
molecul
bind
adjac
antigen
site
virion
monogam
bival
bind
occur
demonstr
electron
microscopi
lafferti
oert
revers
therefor
requir
simultan
dissoci
antibodyviru
bond
probabl
event
proport
squar
probabl
singl
event
lafferti
also
suggest
close
scrutini
methodolog
employ
studi
neutral
could
reconcil
two
view
ie
least
featur
freeli
revers
system
characterist
virusantibodi
interact
preponder
recent
evid
point
virusantibodi
late
complex
firmli
bound
structur
certain
limit
condit
dissoci
complex
actual
demonstr
condit
dissoci
artifact
inher
experiment
procedur
initi
form
monoval
complex
readili
dissoci
time
bival
bind
occur
complex
becom
stabil
degre
stabil
estim
sever
order
magnitud
increas
affin
constant
even
stabil
small
fraction
neutral
popul
readili
dissoci
dilut
presumpt
viru
react
antibodi
low
affin
rate
neutral
depend
antibodi
concentr
test
dilut
dissoci
procedur
prepar
sever
dilut
virusserum
mixtur
assay
infect
dilut
made
reaction
progress
rate
diminish
proport
dilut
inocul
test
host
reaction
continu
vini
interact
suscept
cell
moreov
presenc
host
antiserum
differ
concentr
tend
bia
result
addit
net
result
disproportion
surviv
viru
dilut
fact
due
decreas
n
e
b
traliz
rate
rather
dissoci
one
result
studi
dulbecco
et
al
neutral
anim
virus
focu
attent
phenomenon
call
persist
fraction
observ
fraction
viral
popul
refractori
neutral
antibodi
alreadi
describ
andrew
elford
sever
bacteriophag
burnet
et
al
sever
aniin
virus
respect
phage
examin
andrew
elford
propos
failur
neutral
attribut
genotyp
resist
tendenc
virusantibodi
complex
dissoci
reason
explan
phenomenon
view
andrew
elford
combin
antibodi
occur
hut
without
suffici
effect
negat
infect
view
support
observ
abnorm
small
plaqu
produc
infecti
particl
nonfilter
contrast
control
viru
surviv
particl
design
incomplet
neutral
andrew
elford
interpret
phenomenon
small
number
antibodi
molecul
combin
antigen
determin
viru
distinct
host
combin
determin
presenc
antibodi
constitut
steric
encumbr
therebi
retard
initi
replic
henc
small
plaqu
produc
demonstr
persist
fraction
dulbecco
et
al
anim
virus
mean
plaqu
assay
method
stimul
renew
interest
phenomenon
although
dulbecco
et
al
elimin
sever
explan
eg
dissoci
particip
nonantibodi
serum
compon
hereditari
heterogen
posit
explan
yet
found
subsequ
studi
indic
phenomenon
characterist
wide
varieti
virus
walli
melnick
eg
picornaviru
dulbecco
et
al
mandel
bradish
et
al
walli
melnick
ozaki
fiala
lewentonkriss
mandel
myxoviru
lafferti
b
paramyxoviru
granoff
poxviru
lafferti
b
mcneill
majer
link
togaviru
dulbecco
et
al
princ
rawl
et
ae
ozaki
tabeyi
westaway
hahon
symington
et
al
herpesviru
yoshino
taniguchi
equin
arter
viru
hyllseth
petterson
reoviru
huggett
et
al
bacteriophag
hale
et
al
rappaport
kjellh
observ
gradual
increas
resist
neutral
longer
adenoviru
react
antiserum
consid
result
indic
possibl
requir
increas
antibodi
multipl
dissoci
refractori
practic
signific
phenomenon
emphas
sever
report
show
presenc
infecti
virusantibodi
complex
circulatori
system
ldh
virusinfect
mice
notkin
et
al
visna
virusinfect
sheep
pblsson
toolan
lcminfect
mice
dixon
mink
infect
aleutian
diseas
porter
larson
mlvand
msvinfect
mice
hirsch
et
al
persist
fraction
also
refer
nonneutraliz
fraction
sinc
discuss
section
iv
fraction
neutral
certain
condit
seem
appropri
design
nonneutr
fraction
sever
basic
diverg
hypothes
propos
explain
presenc
nonneutr
fraction
design
use
prefer
persist
fraction
fazeka
de
st
groth
reid
ascrib
simpli
revers
neutral
reaction
ie
dissoci
walli
melnick
consid
unusu
interact
viru
antibodi
occur
howev
format
aggreg
either
interact
antibodi
result
shield
particl
antibodi
somewhat
similar
view
propos
rappaport
differ
howev
one
respect
name
singl
virion
bind
antibodi
may
occur
antigen
determin
leav
other
free
inaccess
henc
particl
retain
infect
bradish
et
al
propos
amphoter
state
virusantibodi
complex
either
viral
antibodi
function
domin
depend
variou
contributori
factor
eg
type
host
cell
compris
test
system
similar
interpret
propos
lafferti
rabbit
poxviru
heterogen
antibodi
popul
given
serum
capac
neutral
induc
nonneutr
state
consid
possibl
lafferti
h
mcneill
lewentonkriss
mandel
ozaki
et
al
hypothes
except
fazeka
de
st
groth
reid
envis
nonneutr
fraction
consist
viru
complex
antibodi
without
absolut
loss
infecti
capabl
recent
ide
yoshino
revis
previou
interpret
nonneutr
state
herpesviru
conclud
fazeka
de
st
groth
reid
freeli
revers
equilibrium
could
account
find
walli
melnick
report
previous
observ
walli
melnick
resist
strain
echoviru
neutral
antiserum
could
overcom
elimin
viral
aggreg
monodispers
state
viru
readili
neutral
extrapol
possibl
repres
variou
group
virus
reveal
hat
everi
case
filtrat
consist
singli
dispers
particl
could
complet
neutral
wherea
unfilt
viru
show
nonneutr
fraction
walli
melnick
analysi
problem
disclos
monodispers
herpesviru
expos
minim
concentr
antibodi
result
virusantibodi
aggreg
becam
nonneutraliz
attempt
investig
elimin
nonneutr
fraction
method
walli
melnick
met
vari
result
reduct
complet
elimin
report
vee
viru
hahon
rhinoviru
fiala
studi
report
filtrat
effect
nonneutr
level
neutral
characterist
ash
et
al
hyllseth
petterson
majer
link
huggett
et
al
lewentonkriss
mandel
although
elimin
short
lag
period
majer
link
slight
increas
neutral
rate
lewentonkriss
mandel
observ
baughman
et
al
describ
complex
result
respiratori
syncyti
viru
filtrat
consider
reduc
nonneutr
fraction
hors
antiserum
use
howev
guinea
pig
serum
use
differ
seen
filter
unfilt
viru
sever
studi
focus
role
host
cell
probabl
strike
illustr
schlesing
outcom
virusantibodi
interact
affect
host
cell
system
serv
indic
neutral
bradish
et
al
observ
aliquot
f
virusantiserum
mixtur
assay
pig
kidney
cell
cultur
mice
show
lower
viral
surviv
latter
host
similar
observ
describ
lafferti
rabbit
poxviru
surviv
consider
lower
test
rabbit
skin
compar
mous
brain
chorioallanto
membran
n
anoth
studi
neutral
poxviru
mcneill
neutral
rate
well
nonneutr
level
vari
accord
whether
assay
done
monkey
kidney
cell
latter
show
higher
rate
lower
final
surviv
level
outcom
neutral
polioviru
assay
hela
monkey
kidney
cell
cultur
result
dulbecco
et
al
lewentonkriss
mandel
howev
interest
observ
made
lewentonkriss
mandel
viru
propag
hela
cell
yield
consider
higher
nonneutr
fraction
viru
propag
monkey
kidney
cell
assay
hela
cell
also
shown
studi
result
mediat
neutral
vari
host
cell
ie
primari
neutral
result
hela
monkey
kidney
cell
antiglobulin
neutral
seen
hela
cell
hahon
survey
five
differ
cell
line
found
level
nonneutralia
vee
viru
studi
stress
bradish
et
al
strongli
impli
nonneutraliz
rel
condit
state
limbo
depend
host
cell
properti
virusantibodi
complex
manifest
consider
interest
center
role
antibodi
establish
nonneutralia
state
evid
present
polioviru
mandel
ldh
viru
notkin
et
al
nonneutr
viru
react
antibodi
sinc
antiserum
prepar
globulin
fraction
viral
antiserum
neutral
part
nonneutr
fraction
becam
interest
determin
viru
neutral
react
uniqu
class
antibodi
antibodi
convent
antigen
combin
essenti
infect
characterist
interact
per
se
uniqu
recognit
infecti
virusantibodi
complex
base
neutral
mediat
antibodi
specif
antivir
serum
globulin
name
mediat
neutral
somewhat
puzzl
observ
describ
capstick
et
al
bradish
et
al
size
nonneutralis
fraction
fmd
viru
invers
relat
serum
concentr
recent
report
symington
et
al
describ
detail
similar
observ
name
highand
lowantibodi
multipl
nonneutr
fraction
sindbi
viru
small
intermedi
multipl
fraction
larg
worker
consid
situat
complex
serum
contain
antibodi
differ
avid
unequ
concentr
differ
antibodi
either
neutral
protect
neutral
vari
concentr
antiserum
one
kind
antibodi
competit
advantag
studi
polioviru
evid
present
implic
antibodi
heterogen
ozaki
svehag
lewentonkriss
mandel
show
level
nonneutr
viru
highest
earliest
collect
antiserum
decreas
later
antiserum
collect
immun
respons
mcneill
suggest
possibl
kind
antibodi
interf
neutral
antibodi
elabor
natur
put
antibodi
studi
rabbit
poxviru
lafferti
conclud
nonneutr
state
attribut
interact
viru
either
two
kind
protect
antibodi
one
case
viru
react
nonavid
antibodi
complex
readili
revers
wash
dilut
n
second
case
viru
bind
firmli
retain
protect
statu
case
complex
condit
infecti
depend
host
system
ozaki
svehag
lewentonkriss
mandel
show
level
nonneutr
fraction
polioviru
decreas
antisera
collect
later
time
immun
respons
westaway
ozaki
et
az
report
similar
observ
sever
togavirus
shown
svehag
chronolog
immun
respons
character
success
chang
class
antibodi
produc
well
qualit
chang
within
class
antibodi
produc
earli
predominantli
macroglobulin
type
low
bind
affin
succeed
type
tend
time
increas
bind
affin
similar
relationship
shown
exist
respons
individu
activ
infect
polioviru
brunner
ward
ogra
et
al
arboviru
bellanti
et
al
mump
viru
daugharti
et
al
coxsackieviru
schmidt
et
al
influenza
viru
brown
oleari
observ
tend
incrimin
specif
type
antibodi
caus
nonneutr
state
hahon
prepar
nonneutr
vee
viru
human
antivir
antiserum
mediatcd
neutral
prepar
antihuman
igg
iga
igm
goat
antiigg
antiiga
sera
effect
latter
somcwhat
less
antiigm
secondari
neutral
activ
also
shown
goat
antihuman
fab
antifc
sera
secondari
neutral
activ
latter
quit
weak
result
implic
igg
iga
nonneutr
antibodi
absenc
antiigm
activ
indic
cithcr
class
antibodi
involv
absent
virusspecif
antiserum
similar
result
describ
notkin
et
az
studi
ldh
viru
sensit
mous
immun
serum
goat
antimous
globulin
neutral
sensit
viru
rabbit
antimous
igg
iga
igf
neutral
sensit
viru
rabbit
antimous
igm
ineffect
anoth
aspect
studi
shown
monoval
fab
fragment
goat
antimous
globulin
partial
neutral
block
remaind
neutral
undigest
antimous
globulin
ozaki
et
al
obtain
antisera
jev
earli
day
late
day
neutral
show
nonneutr
fraction
case
level
higher
earli
serum
neutral
antibodi
earli
late
sera
igm
igg
respect
goat
antirabbit
igm
serum
neutral
nonneutr
fraction
earli
serum
use
wherea
antiigg
without
effect
viru
neutral
late
serum
antiigg
reduc
nonneutr
fraction
slightli
antiigm
specif
seen
direct
neutral
carri
fraction
antivir
igm
igg
challeng
fraction
antiantibodi
possibl
occurr
uniqu
class
antibodi
specif
induc
nonneutr
state
investig
attempt
isol
lewentonkriss
mandel
earli
rabbit
polioviru
antiserum
fraction
three
unrel
procedur
gradient
centrifug
chromatograph
separ
use
sephadex
molecular
siev
isoelectr
focus
electrophoresi
n
instanc
antibodi
activ
detect
neutral
accompani
nonneutr
fraction
igg
igm
fraction
hors
antirabbit
secondari
neutral
activ
igm
fraction
activ
molar
basi
implic
role
antibodi
nonneutraliz
describ
hashimoto
princ
result
nonneutr
fraction
bev
react
rabbit
antiserum
excess
could
neutral
part
guinea
pig
antiviru
antiserum
howev
result
nonneutr
fraction
guinea
pig
antiserum
excess
use
affect
rabbit
antiserum
perhap
guinea
pig
antiserum
contain
low
level
function
complement
also
shown
polioviru
svehag
eewentonkriss
mandel
jev
ozaki
st
al
nonneutr
fraction
induc
earli
rabbit
immun
serum
neutral
late
immun
serum
rabbit
n
instanc
direct
use
late
serum
reduc
infect
consider
lower
level
level
nonneutr
fraction
result
use
earli
serum
observ
consist
dissoci
hypothesi
sinc
later
appear
antibodi
greater
bind
affin
abl
replac
weaker
earli
antibodi
rappaport
propos
nonneutr
condit
result
incomplet
bind
antibodi
antigen
determin
show
nonneutr
fraction
icosahedr
rna
bacteriophag
repres
particl
halfsatur
antibodi
henc
particl
protect
addit
bind
antibodi
yet
retain
infecti
capabl
n
studi
herpesviru
yoshino
morishima
arriv
similar
interpret
fazeka
de
st
groth
reid
propos
data
dulbecco
et
nl
support
dissoci
hypothesi
nonneutr
fraction
ide
yoshino
reevalu
interpret
nonneutr
state
herpesviru
favor
dissoci
hypothesi
experiment
basi
observ
level
surviv
viru
diminish
filtrat
virusserum
mixtur
incub
worker
consid
evid
reequilibr
sinc
virusantibodi
complex
antibodi
free
viru
retain
filter
failur
alter
nonneutr
fraction
alter
concentr
antibodi
explain
basi
equilibrium
establish
antibodi
total
number
critic
reactiv
site
rather
number
viral
particl
henc
exampl
consider
dilut
possibl
consider
time
may
requir
detect
sign
dissoci
ie
increas
infect
correl
high
nonneutr
fraction
earli
serum
togeth
known
low
affin
earli
antibodi
either
igm
igg
suggest
possibl
nonneutr
fraction
polioviru
result
defect
reaction
lewentonkriss
mandel
evid
neutral
culmin
sequenti
event
begin
union
viru
antibodi
therefor
propos
lewentonkriss
mandel
either
defect
antibodi
improp
bind
antibodi
viru
reaction
go
complet
addit
antibodi
specif
virusassoci
antibodi
activ
abort
reaction
similar
interpret
appli
mediat
neutral
nonneutr
fraction
herpesviru
yoshino
isono
studi
stemk
lennox
neutral
bacteriophag
disclos
fab
fragment
deriv
hyperimmun
rabbit
antiseruni
neutral
activ
although
fab
fragment
higher
neutral
capac
fab
fragment
addit
antiglobulin
goat
antirabbit
globulin
increas
neutral
final
level
therefor
conclud
fragment
bound
equal
well
quantit
howev
fab
fragment
lower
neutral
potenti
possibl
consid
distinct
bind
site
exist
two
fragment
antiglobulin
use
goodman
donch
demonstr
l
chain
deriv
rabbit
antitl
serum
react
bacteriophag
per
se
chain
question
neutral
activ
activ
enhanc
appreci
level
goat
antirabbit
globulin
kinet
examin
effect
antiglobulin
bacteriophag
neutral
dudley
et
al
show
rate
neutral
bacteriophag
icosahedr
rna
viru
antibodi
pepsinderiv
fragment
fragment
deriv
fragment
enhanc
threefold
addit
antiserum
respect
globulin
fraction
evid
present
support
variou
hypothes
although
interpret
attempt
confirm
instanc
led
conclus
n
broad
sens
hypothes
reduc
two
nonneutr
fraction
result
dissoci
virusantibodi
complex
viru
react
antibodi
without
lose
infect
b
acquir
protect
statu
support
latter
evid
present
clump
may
respons
evid
also
present
singl
particl
involv
sinc
monoval
fragment
viral
antibodi
well
monoval
fragment
antiantibodi
particip
phenomenon
although
cluinp
hypothesi
provid
possibl
explanatipn
protect
statu
explan
evid
monodispers
viru
nonneutr
state
possibl
abort
reaction
hypothesi
stage
reaction
sequenc
reach
short
ncutral
render
viral
capsid
nonantigen
studi
bacteri
virus
shown
nonneutr
fraction
occur
earli
studi
andrew
elford
recent
studi
eg
hale
et
al
presumpt
nonneutr
fraction
result
unusu
virusantibodi
reaction
anim
virus
nonneutr
fraction
subject
neutral
antiantibodi
also
anim
virus
report
indic
igm
antibodi
involv
wherea
report
state
igg
antibodi
involv
howev
unanim
observ
antibodi
synthes
earli
rather
late
immun
respons
respons
nonneutr
state
sinc
also
common
observ
earli
antibodi
rel
weak
bind
capabl
characterist
like
directli
concern
nonneutr
studi
antibodi
fragment
stemk
lennox
shown
although
fab
higher
neutral
capabl
fab
interact
viru
degre
shown
mediat
antiantibodi
interact
fab
antigen
may
less
like
result
neutral
fab
interact
also
worthi
note
aggreg
basi
interact
sinc
reaction
involv
monoval
fragment
present
time
experiment
data
account
refractori
state
nonneutr
fraction
possibl
infecti
virusantibodi
complex
steric
hinder
antigen
capsid
modifi
viru
could
react
antibodi
without
loss
infecti
capabl
suspect
andrew
elford
evid
support
presumpt
report
polioviru
mandel
ldh
viru
notkin
et
al
polioviru
surviv
exposur
rabbit
antiserum
ldh
viru
surviv
exposur
mous
antiserum
neutral
antirabbit
globulin
antimous
globulin
sera
respect
notkin
et
al
refer
infecti
virusantibodi
complex
sensit
viru
appropri
design
indic
observ
complex
sensit
sever
factor
sensit
manifest
loss
infect
involv
complement
system
viral
neutral
suspect
earli
gordon
report
loss
neutral
activ
sera
rabbit
immun
vaccinia
viru
heat
howev
loss
could
restor
addit
fresh
normal
guinea
pig
serum
similar
observ
report
dougla
smith
tanaka
imagawa
implic
presenc
thermolabil
accessori
substanc
sera
deriv
anim
immun
vaccinia
viru
detail
investig
phenomenon
describ
mueller
presenc
thermolabil
substanc
particip
neutral
rou
sarcoma
viru
shown
present
sera
gees
duck
chicken
rabbit
immun
rou
viru
neutral
activ
lost
consequ
heat
minut
could
restor
addit
guinea
pig
serum
fresh
heat
result
prompt
mueller
suggest
thermolabil
substanc
alexin
ie
complement
awar
probabl
role
complement
neutral
mump
viru
human
sera
leymast
ward
stress
need
preserv
activ
appropri
handl
procedur
interest
observ
sera
individu
long
year
inuinp
infect
still
show
depend
thermolabil
serum
compon
similar
caution
express
pollikoff
sigel
respect
sera
neutral
activ
lcm
viru
arenaviru
anoth
instanc
depend
antiserum
thermolabil
serum
factor
report
adam
imagawa
involv
sera
ferret
immun
mouseadapt
strain
distemp
viru
howitt
howev
unabl
detect
neutral
accessori
substanc
sera
hors
immun
equin
encephalomyel
viru
neutral
activ
affect
neither
heat
minut
addit
complement
result
necessarili
challeng
credibl
previou
observ
sinc
light
recent
knowledg
stage
antibodi
respons
complementdepend
probabl
pass
sinc
howitt
state
anim
hyperimmun
independ
neutral
activ
also
report
strong
human
sera
capabl
neutral
presum
herpeslik
viru
viru
w
neither
heat
known
complementdeactiv
procedur
effect
neutral
anoth
studi
question
role
complement
presenc
accessori
substanc
report
ginsberg
horsfal
sera
normal
ie
knowingli
expos
immun
virus
studi
human
rabbit
guinea
pig
mice
neutral
activ
influensa
viru
mump
viru
ndv
lost
activ
upon
heat
minut
storag
week
deplet
decomplement
sera
devoid
activ
result
heat
storag
reactiv
addit
fresh
serum
child
prior
histori
mump
influenza
infect
although
investig
cogniz
similar
characterist
complement
accessori
substanc
consid
latter
distinct
complement
certain
quantit
discrep
whitman
suspect
presenc
neutral
accessori
substanc
serum
individu
convalesc
infect
wee
viru
neutral
activ
decreas
disproportion
serum
dilut
suspect
presenc
accessori
factor
confirm
suspicion
demonstr
thermolabil
charact
augment
neutral
activ
addit
guinea
pig
serum
heat
minut
immun
serum
spite
similar
complement
accessori
substanc
whitman
conserv
eschew
specif
label
activ
materi
somewhat
earlier
morgan
report
discrep
quantit
aspect
neutral
wee
viru
immun
rabbit
sera
relat
use
fresh
heat
serum
addit
complement
latter
tend
elimin
discrep
anoth
togaviru
dengu
report
sabin
neutral
complementdepend
antibodi
present
serum
convalesc
monkey
note
previou
studi
led
discrep
conclus
presenc
natur
substanc
immun
sera
act
conjunct
specif
antibodi
leymast
ward
attempt
refin
experiment
system
use
viru
mump
capabl
assay
host
devoid
complement
ie
embryon
chicken
egg
sera
immun
monkey
human
case
mump
infect
either
acut
convalesc
stage
contain
neutral
activ
nullifi
heat
decomplement
addit
either
case
fresh
sera
obtain
children
less
year
age
restor
neutral
activ
worker
attribut
restor
complement
n
studi
cite
thu
far
virus
investig
myxovirus
togavirus
poxvirus
virion
contain
lipidrich
envelop
presenc
envelop
requir
complementdepend
neutral
shown
sever
studi
involv
envelopefre
bacteri
virus
n
hershey
bronfenbrenn
describ
particip
complement
neutral
two
coliphag
enigmat
aspect
brief
report
indic
instanc
virusserum
mixtur
react
complet
show
partial
reactiv
upon
subsequ
addit
complement
particip
complement
neutral
bacteriophag
also
report
barlow
et
cowan
toussaint
muschel
perni
et
al
adler
et
al
harri
et
al
report
induct
human
mice
complementdepend
antibodi
follow
immun
bacillu
megatherium
bacteriophag
interest
observ
addit
normal
fresh
mous
serum
moder
concentr
heatinactiv
mous
antiserum
restor
activ
howev
high
concentr
reactiv
ensu
order
establish
rigor
ident
thermolabil
accessori
factor
complement
dozoi
et
al
fraction
rabbit
serum
contain
antibodi
wee
viru
well
accessori
factor
remov
complement
system
deplet
serum
neutral
activ
rcconstitut
serum
neutral
activ
restor
detail
reconstitut
procedur
indic
compon
complement
system
essenti
wherea
compon
either
requir
requir
trace
concentr
studi
two
togavirusc
murray
valley
enceph
wn
enceph
describ
westaway
unlik
wee
murray
valley
enceph
viru
neutral
slightli
effici
ad
complement
wherea
wn
viru
neutral
perhap
slightli
inhibit
addit
guinea
pig
serum
anoth
instanc
complementindepend
neutral
togaviru
jev
report
hashimoto
princ
addit
fresh
guinea
pig
serum
either
earli
late
immun
rabbit
sera
affect
neither
rate
degre
neutral
unusu
observ
studi
spontan
partial
reactiv
neutral
viru
rel
late
kinet
analysi
reaction
ozaki
tabeyi
observ
mark
enhanc
neutral
actviti
jev
fresh
guinea
pig
serum
rate
extent
neutral
increas
result
contrast
result
report
hashimoto
princ
possibl
relev
differ
result
observ
iwasaki
ogur
jev
grown
porcin
cell
induc
complementdepend
antibodi
specif
viral
antigen
well
antibodi
specif
host
lipoprotein
compris
viral
envelop
howev
viru
grown
mous
brain
insensit
complementdepend
antibodi
wherea
ozaki
tabeyi
use
viru
cultiv
porcin
cell
hashimoto
princ
use
viru
deriv
infect
suckl
mous
brain
baughman
et
al
report
antibodi
guinea
pig
ferret
immun
respiratori
syncyti
viru
markedli
complementdepend
although
antibodi
hors
appear
independ
end
point
analysi
complement
effect
observ
increas
neutral
reaction
rate
common
observ
sera
obtain
normal
individu
contain
neutral
substanc
probabl
immatur
antibodi
array
virus
rule
thumb
distinguish
normal
antibodi
inhibitori
substanc
greater
thermol
latter
inabl
replac
latter
complement
mccarthi
genner
examin
normal
sera
guinea
pig
rabbit
human
neutral
activ
variola
viru
herpesviru
cowpox
viru
posit
sera
lost
activ
heat
c
activ
regain
upon
addit
fresh
serum
investig
propos
posit
sera
contain
two
separ
neutral
factor
act
independ
perhap
envis
two
class
antibodi
one
requir
complement
independ
complement
howitt
survey
sera
variou
anim
speci
presenc
normal
neutral
activ
ndv
speci
examin
includ
known
high
level
complement
eg
human
monkey
rabbit
guinea
pig
speci
littl
complement
eg
ferret
hamster
chicken
sera
human
monkey
rabbit
guinea
pig
neutral
ndv
test
fresh
lack
activ
heat
minut
absenc
neutralh
activ
fresh
sera
ferret
hamster
chick
abil
negat
activ
heat
sera
complementrich
speci
suggest
role
complement
neutral
activ
normal
sera
studi
natur
bacteriophageneutr
substanc
normal
human
sera
led
muschel
toussaint
conclud
substanc
antibodi
qualit
indistinguish
antibodi
appear
earli
immun
respons
instanc
neutral
antibodi
complementdepend
recent
bendinelli
et
al
report
distribut
normal
antibodi
among
variou
speci
anim
n
presenc
complement
endogen
ad
sera
variou
speci
mous
rat
sheep
neutral
friend
leukemia
viru
bccaus
sensit
heat
minut
requir
dival
cation
restor
deactiv
sera
addit
complement
worker
consid
thc
neutral
activ
result
complementdepend
antibodi
sever
studi
rubella
equin
artcriti
viru
togavirus
alphaviru
subgroup
shown
antibodi
virus
may
complementdepend
neva
weller
parkman
et
al
leerhoy
rawl
et
al
examin
sera
infant
rubella
infect
mother
infant
year
infect
adult
year
infect
n
instanc
addit
complement
heat
sera
increas
degre
neutral
activ
decomplement
result
reduc
activ
interest
investig
unlik
herpesviru
rubella
viru
induc
complementdepend
antibodi
long
infect
leerhoy
observ
wherea
guinea
pig
hors
sera
effect
enhanc
neutral
activ
human
serum
rubella
viru
rabbit
calf
sera
rel
poor
sinc
hors
sera
lack
leerhoy
compon
complement
particip
system
howev
maess
consid
limit
factor
complementdepend
neutral
equin
arter
viru
conclus
base
distribut
activ
follow
dialysi
guinea
pig
serum
complementeffect
activ
hyllseth
petterson
also
report
complementdepend
neutral
antibodi
equin
arter
viru
serum
immun
rabbit
well
postinfect
serum
hors
kinet
studi
use
hors
serum
sourc
antibodi
show
slow
rate
neutral
addit
complement
ie
fresh
guinea
pig
serum
hour
start
homolog
reaction
result
instanc
rapid
extens
neutral
reaction
homolog
well
complementeffect
kinet
singlehit
radwan
burger
b
demonstr
antibodi
hors
guinea
pig
rabbit
hamster
mice
immun
equin
arter
viru
complementdepend
depend
antibodi
found
lateappear
igg
earli
igg
igm
nonneutr
either
per
se
complement
studi
radwan
et
al
show
addit
complement
viru
complex
depend
antibodi
eventu
result
lysi
viral
membran
howev
use
trypsin
shown
neutral
preced
viral
lysi
previou
studi
neutrah
coronaviru
avian
infecti
bronchiti
berri
almeida
shown
complementdepend
neutral
occur
absenc
viral
lysi
antiserum
devoid
antibodi
lipoprotein
envelop
presenc
antibodi
lysi
observ
electron
microscopi
recent
studi
complementeffect
neutral
focus
role
variou
compon
complement
system
perhap
appropri
point
outlin
salient
featur
complement
comprehens
recent
exposit
subject
reader
refer
osler
review
briefer
discuss
orient
subject
hand
two
reaction
pathway
definedclass
altern
classic
system
consist
glycoprotein
function
aggreg
caz
requir
n
presenc
antigenantibodi
complex
first
compon
conglomer
clq
clr
cl
bind
antibodi
complex
thereupon
compon
order
bind
success
forerunn
complex
compon
exist
precursor
state
activ
result
bind
eg
acquir
esteras
activ
activ
compon
eg
undergo
partial
cleavag
activ
esteras
coniplementinduc
cell
lysi
entir
sequenc
reaction
requir
initi
reaction
antibodi
cellular
surfac
antigen
shown
entir
complement
system
may
requir
complementeff
ect
neutral
altern
pathway
involv
activ
properdin
basic
glycoprotein
sever
addit
cofactor
present
serum
final
product
altern
system
therefor
function
absenc
biochem
studi
elucid
characterist
isol
method
individu
compon
thu
allow
analysi
individu
role
discoveri
specif
inhibitor
ad
investig
versatil
system
exampl
zymosan
cobra
venom
destroy
thu
classic
pathway
nonfunct
differenti
thermol
allow
select
inactiv
altern
pathway
minut
classic
pathway
minut
final
sera
obtain
anim
genet
defect
specif
compon
absent
complex
virusantibodycompl
interact
compound
molecular
heterogen
differ
class
antibodi
divers
reaction
viral
antigen
differenti
capac
activ
complement
system
first
stage
complement
activ
bind
c
l
q
compon
fc
hing
region
antibodi
molecul
igm
pentam
igg
far
greater
potenti
activ
complement
variat
capac
activ
complement
exist
among
subclass
igg
eg
rat
capabl
studi
human
myeloma
protein
spiegelberg
reveal
iggl
activ
wherea
incap
activ
complement
complex
system
ramifi
variabl
sensit
given
complement
system
antibodi
differ
origin
exampl
guinea
pig
complement
react
maxim
homolog
antibodi
half
well
rabbit
antibodi
feebli
dog
antibodi
chicken
antibodi
furthermor
homolog
reaction
necessarili
optim
shown
threefold
greater
reactiv
rabbit
complement
guinea
pig
antibodi
rabbit
antibodi
gigli
austen
n
view
complex
natur
complement
activ
failur
effect
viral
neutral
complement
may
due
much
inappropri
system
real
insensit
sever
previous
cite
studi
shown
abil
effect
viral
neutral
complement
relat
antibodi
development
stage
immun
respons
antibodi
appear
earli
react
viru
either
without
neutral
neutral
poorli
either
case
addit
complement
enhanc
degre
neutral
contrast
late
antibodi
independ
complement
studi
chronolog
appear
differ
class
antibodi
uhr
et
nl
uhr
uhr
finkelstein
svehag
mandel
b
grave
et
al
brown
et
al
mckercher
giordano
ogra
et
al
indic
igm
antibodi
preced
igg
howev
osler
indic
use
appropri
method
respons
nonvir
iinmunogen
human
serum
albumin
rabbit
guinea
pig
within
first
week
predominantli
igg
antibodi
although
igg
antibodi
exceed
amount
igm
molar
basi
igg
antibodi
detect
convent
serolog
rcaction
like
therefor
affin
earli
igg
antibodi
low
order
magnitud
cowan
also
qucstion
interpret
data
n
studi
detect
earli
igm
base
sensit
howev
recogn
recent
earli
igg
similar
sensit
studi
recognit
type
antibodi
base
separ
densiti
gradient
centrifug
molecular
siev
yoshino
taniguchi
report
earli
antibodi
rabbit
elicit
immun
corneal
infect
herpesviru
could
neutral
complement
present
antibodi
appear
later
complementindepend
studi
yoshino
taniguchi
show
depend
independ
antibodi
igg
class
resist
thermal
inactiv
c
minut
resist
inactiv
reduct
also
shown
yoshino
taniguchi
antibodi
induc
guinea
pig
immun
human
follow
herp
infect
initi
depend
later
independ
complement
neutral
activ
addit
observ
made
herp
antibodi
normal
individu
e
current
recent
infect
complementindepend
henc
presenc
complementdepend
neutral
antibodi
diagnost
signific
detail
character
antibodi
respons
describ
shinkai
yoshino
earli
sera
herpesimmun
rabbit
guinea
pig
fraction
rabbit
sera
contain
complementdepend
antibodi
igm
fast
igg
slow
igg
class
depend
antibodi
guinea
pig
serum
princip
slow
jgg
ie
late
rabbit
sera
contain
littl
igm
igg
antibodi
longer
complementdepend
unlik
guinea
pig
serum
continu
synthes
depend
igg
reimmun
rabbit
elicit
brief
respons
depend
igm
burst
independ
igg
follow
primari
herp
infect
human
three
categori
antibodi
describ
heineman
total
complementdepend
potenti
independ
data
permit
interpret
potenti
conceiv
refer
presenc
antibodi
categori
basic
similar
result
describ
bacteri
virus
hbjek
immun
newborn
rabbit
bacteriophag
sera
collect
day
later
contain
complementdepend
thennolabil
antibodi
day
complementdepend
antibodi
day
partial
depend
antibodi
day
investig
suggest
transit
indic
gradual
enhanc
bind
strength
antibodi
time
immun
relat
studi
hhjek
hltjek
mandel
show
wherea
normal
earli
immun
antibodi
complementdepend
normal
earli
immun
antibodi
bacteriophag
independ
possibl
explan
differ
behavior
two
virus
propos
bind
affin
antibodi
antigen
determin
characterist
affin
rel
simpl
small
icosahedr
bacteriophag
suffici
high
requir
augment
investig
state
sourc
normal
serum
newborn
pig
allow
receiv
colostrum
sera
contain
neutral
activ
either
perni
et
al
compar
antibodi
bacteriophag
obtain
normal
newborn
normal
adult
immun
adult
rabbit
neutral
newborn
serum
requir
complement
unlik
adult
sera
irrevers
addit
fresh
serum
loss
activ
heat
minut
occur
newborn
adult
normal
sera
treatment
edta
zymosan
elimin
activ
normal
sera
worker
attribut
complementdepend
neutral
thermolabil
antibodi
result
treatment
implic
earli
compon
cl
classic
pathway
complementeffect
neutral
recent
studi
schrader
muschel
phage
tzrabbit
antibodi
interact
indic
antibodi
collect
period
day
singl
immun
depend
compon
interestingli
observ
addit
less
effect
addit
alon
neutral
antibodi
activ
complet
complement
system
ie
whole
guinea
pig
serum
studi
complement
depend
herp
antibodi
induc
rabbit
reveal
interest
observ
antibodi
obtain
hyperimmun
independ
complement
test
end
point
titer
howev
antibodi
assay
kinet
analysi
show
increas
reaction
rate
constant
presenc
complement
studi
serolog
relationship
human
simian
herpesvirus
steven
et
al
observ
other
depend
complement
earli
antibodi
late
antibodi
type
matur
independ
unlik
late
antibodi
previous
westaway
examind
serolog
relationship
among
groupb
arbovirus
flavivirus
inclus
fresh
normal
rabbit
guinea
pig
sera
neutral
reaction
enhanc
quantit
result
howev
westaway
question
desir
procedur
case
inasmuch
effect
enhanc
specif
reaction
known
sever
studi
neutral
cmv
current
classifi
herpesviru
yield
diverg
result
rabbit
immun
strain
specif
human
andersen
observ
earli
appear
complementfix
antibodi
incap
neutral
even
presenc
complement
although
late
sera
contain
neutral
antibodi
complement
requir
late
week
hyperimmun
pursu
studi
andersen
describ
failur
detect
neutral
antibodi
either
complementdepend
independ
earli
sera
infect
human
subject
although
complementfix
antibodi
present
antisera
rabbit
prepar
two
human
strain
two
simian
strain
davi
human
strain
late
sera
contain
complementindepend
antibodi
simian
strain
antibodi
depend
complement
neutral
anoth
studi
graham
et
prepar
antisera
primat
baboon
monkey
two
human
strain
two
monkey
strain
hyperiminun
sera
human
virus
contain
complementdepend
antibodi
class
wherea
antibodi
monkey
strain
independentth
revers
result
obtain
andersen
graham
et
al
also
indic
antibodi
goat
hyperimmun
human
strain
complementdepend
primat
antisera
worker
stress
need
inclus
freund
adjuv
obtain
reason
high
level
circul
antibodi
whether
use
adjuv
effect
qualiti
class
antibodi
discuss
minamishima
et
al
character
cmv
antibodi
obtain
subhuman
primat
wild
complementindepend
antibodi
detect
simian
strain
cmv
sera
test
neutral
human
cmv
strain
one
strain
neutral
complement
present
second
strain
neutral
final
ablashi
et
al
describ
success
immun
rabbit
simian
strain
success
case
indic
product
antibodi
complementindepend
elucid
natur
mode
action
complement
attempt
undertaken
determin
basi
complement
particip
neutral
shortli
discoveri
properdin
role
altern
complement
pathway
understood
van
vunaki
et
al
attempt
determin
function
neutral
phage
normal
human
sera
heat
minut
addit
edta
addit
aymosan
nullifi
neutral
activ
zymosantr
sera
howev
retain
hemolyt
activ
light
recent
knowledg
data
implic
one
earlyact
compon
cl
neutral
inasmuch
altern
pathway
function
earli
suspect
implic
role
properdin
viral
neutral
discuss
ginsberg
wedgwood
taniguchi
yoshino
examin
role
complement
neutral
herpesviru
earli
rabbit
antibodi
immun
serum
depriv
neutral
activ
heat
minut
zymosan
ammonium
hydroxid
treatment
individu
compon
complement
ie
obtain
fraction
guinea
pig
sera
ad
singli
combin
deactiv
rabbit
serum
four
compon
optim
concentr
ad
rabbit
serum
reacquir
neutral
activ
earlier
studi
phenomenon
dozoi
et
al
rabbit
antibodi
wee
viru
examin
result
somewhat
differ
conclus
wherea
compon
requir
compon
either
dispens
requir
trace
amount
least
one
differ
methodolog
employ
two
studi
involv
sourc
complement
compon
name
guinea
pig
sera
rabbit
sera
respect
yet
anoth
interpret
phenomenon
propos
daniel
et
al
viru
allow
react
isol
igm
antibodi
earli
rabbit
antiserum
virusantibodi
complex
isol
centrifug
shown
infecti
neutraliz
complement
addit
either
activ
without
effect
addit
result
neutral
compon
manifest
activ
present
optim
concentr
suboptim
concentr
depend
first
four
complement
compon
neutral
ndv
earli
rabbit
igm
antibodi
describ
linscott
levinson
neutral
enhanc
fresh
guinea
pig
serum
negat
treatment
heat
dival
cation
deplet
cobra
venom
activ
restor
first
four
compon
ad
treat
serum
similar
conclus
interest
ramif
report
oldston
et
al
antibodi
polyoma
nonenvelop
viru
induc
rabbit
aid
freund
incomplet
adjuv
antibodi
igg
class
isol
heat
antisera
depend
complement
function
multipl
bound
antibodi
molecul
per
virion
requir
complement
multipl
viru
sensit
therefor
neutraliz
fresh
serum
neutral
also
effect
serum
ccdefici
serum
neutral
effect
c
l
q
alon
combin
combin
posit
result
c
l
q
attribut
abil
aggreg
virusantibodi
complex
investig
indic
effect
academ
interest
sinc
c
l
q
normal
found
free
state
serum
rather
conglomer
clqclrcl
ie
variou
studi
complementeffect
neutral
sever
mechan
account
phenomenon
propos
accumul
complement
virionantibodi
complex
produc
shield
steric
reason
prevent
viral
function
complement
compon
crosslink
juxtapos
virionantibodi
complex
result
format
aggreg
envelop
virus
interact
virionantibodi
complex
complet
compleni
system
result
lytic
lesion
membran
base
hypothesi
neutral
termin
stage
multistag
phenomenon
complement
supplement
reaction
absenc
fail
go
complet
complement
stabil
virusantibodi
complex
otherwis
readili
dissoci
dilut
daniel
et
al
daniel
et
al
observ
complement
compon
fail
effect
neutral
herpesviru
combin
depend
antibodi
howev
subsequ
addifion
result
neutral
worker
propos
therefor
thc
addit
accumul
compon
suffici
interfer
steric
viral
infect
similar
interpret
propos
linscott
levinson
complementeffect
neutral
ndv
latter
worker
stress
exponenti
manner
success
compon
complement
accumul
eg
one
molecul
bound
may
initi
bind
sever
thousand
molecul
direct
support
propos
amass
complement
virionantibodi
complex
provid
electron
microscopi
berri
almeida
evid
substanti
aggreg
hypothesi
base
filtrat
sediment
analys
studi
herpesviru
walli
melnick
walli
shown
filter
complex
viru
depend
antibodi
becam
nonfilter
react
complement
attributcd
format
rel
larg
aggreg
howev
virionantibodi
complexc
highli
dilut
time
addit
complement
neutral
without
loss
filter
result
henc
latter
condit
complement
exert
effect
stcric
hindranc
specul
natur
complementdepend
antibodi
walli
melnick
suggest
function
monoval
molccul
oldston
et
al
oldston
et
al
demonstr
aggreg
polyoma
virusantibodi
complex
increas
sediment
ratc
addit
averag
two
molecul
antibodi
per
virion
increas
sediment
ratc
first
four
compon
complement
ad
sediment
rate
increas
indic
aggreg
crosslink
action
complement
studi
viru
doubli
label
radioisotop
thercbi
allow
individu
track
capsid
genom
although
sediment
rate
increas
infect
neutral
virion
remain
intact
base
cosediment
capsid
genom
radioact
marker
note
polyoma
simpl
nonenvelop
viru
notkin
et
al
examin
effect
complement
herpesviru
complex
igm
complementdepend
antibodi
although
addit
complement
pool
guinea
pig
sera
reduc
infect
investig
observ
littl
effect
sediment
rate
reason
differ
result
presum
similar
system
ie
herpesantibodycompl
discern
yoshino
taniguchi
demonstr
stabil
complex
herpesviru
complementdepend
antibodi
neither
extens
dilut
sonic
promot
dissoci
also
shown
complex
adsorb
host
cell
continu
show
sensit
complcment
henc
cellular
induc
dissoci
occur
yoshino
colleagu
reject
steric
hindranc
basi
complementeffect
neutral
base
filtrat
studi
yoshino
kishi
kinet
analys
singlehit
kinet
observ
sensit
complementeffect
neutral
yoshino
et
al
shown
avian
infecti
bronchiti
viru
berri
almeida
equin
arter
viru
radwan
et
al
appropri
condit
irrevers
damag
viral
envelop
accompani
neutral
presenc
complement
howev
also
shown
neutral
occur
absenc
envelop
damag
culmin
extens
studi
complementeffect
neutral
herpesviru
yoshino
colleagu
follow
hypothesi
propos
yoshino
isono
antibodi
distinguish
function
physicochem
neutral
sensit
effect
neutral
antibodi
per
se
capabl
initi
sequenti
reaction
termin
neutral
infect
contrast
reaction
initi
depend
antibodi
fail
go
complet
propos
wherea
earliest
stage
neutral
pathway
influenc
complement
later
stage
requir
progress
decreas
amount
complement
studi
yoshino
isono
discern
differ
antibodi
respect
far
antibodi
could
drive
reaction
complementindepend
antibodi
eg
late
igg
drove
reaction
complet
decreas
order
capabl
depend
late
earli
igg
late
igm
earli
igm
propos
base
concept
mandel
neutral
one
molecul
antibodi
initi
con
format
transit
neighbor
capsid
subunit
net
result
overal
capsid
alter
evid
underli
concept
obtain
picornaviru
yoshino
isono
recogn
risk
extend
concept
envelop
viru
herpesviru
howev
consid
possibl
reactiv
surfac
antigen
protrus
underli
protein
continuum
role
complement
vivo
interact
herpesviru
antibodi
recent
examin
strunk
et
al
guinea
pig
genet
defici
synthesi
compar
genet
compet
guinea
pig
follow
infect
herpesviru
group
show
level
infect
normal
anim
show
util
infect
investig
suggest
therefor
classic
pathway
involv
viral
clearanc
possibl
altern
pathway
activ
styk
et
al
report
presenc
normal
sera
substanc
act
conjunct
antibodi
inhibit
influenza
viru
subsequ
investig
styk
colleagu
styk
colleagu
styk
colleagu
styk
styk
styk
hana
et
al
kociskova
et
al
styk
hana
carri
character
substanc
call
cofactor
strain
influenza
viru
use
antibodi
activ
base
primarili
inhibit
hemagglutin
occasion
neutral
natur
cofactor
found
distinct
froin
complement
compon
although
distinct
instanc
equivoc
electrophoret
migrat
globulin
base
exclus
chromatograph
analysi
macroglobulin
found
thermolabil
resist
trypsin
period
consid
lipoprotein
norin
sera
human
mice
hors
pig
cattl
contain
cofactor
unlik
cofactor
sera
cofactor
guinea
pig
requir
dival
cation
propos
mode
action
resembl
complement
antiglobulin
name
combin
antibodi
react
antigen
n
cofactor
reduc
probabl
dissoci
virusantibodi
complex
addit
presenc
increas
degre
steric
hindranc
normal
viral
function
evid
cofactor
react
directli
viru
relationship
cofactor
antibodi
class
studi
antibodi
appear
earli
immun
respons
sensit
cofactor
late
antibodi
character
antibodi
class
show
antibodi
late
antibodi
sensit
investig
consid
interest
possibl
earli
immun
respons
may
consist
antibodi
cofactordepend
howev
procedur
usual
employ
separ
antibodi
type
also
segreg
cofactor
antibodi
henc
although
antibodi
may
present
demonstr
presenc
requir
cofactor
separ
base
conjectur
investig
found
instanc
earli
respons
consist
antibodi
requir
cofactor
depend
antibodi
consid
imperfect
contrast
classic
antibodi
polyak
et
al
confirm
conclus
styk
colleagu
cofactor
complement
differ
entiti
smorodintsev
yabrov
extend
observ
strain
influenza
viru
well
sendai
viru
n
interpret
nonspecif
thermolabil
stimul
antibodi
function
stabil
complex
viru
nonavid
antibodi
involv
rheumatoid
factor
mediat
neutral
describ
recent
herpesviru
ash
et
al
vaccinia
viru
gipson
et
al
hepat
viru
markenson
et
al
rheumatoid
factor
circulatori
igm
antibodi
appear
respons
r
varieti
patholog
condit
consid
specif
host
igg
may
undergon
alter
result
bind
foreign
antigen
shown
ash
et
az
herpesviru
sensit
igg
antibodi
complex
bound
rheumatoid
factor
howev
tripartit
complex
still
infecti
acquir
sensit
complement
antihuman
igm
loss
infect
also
shown
use
fab
fragment
viral
antibodi
fc
portion
antibodi
molecul
bind
region
rheumatoid
factor
also
report
austin
staphylococc
protein
effect
secondari
neutral
mediat
secondari
neutral
herpesviru
vaccinia
viru
like
rheumatoid
factor
protein
hind
fc
region
igg
complex
viru
n
instanc
neutral
effect
instanc
requir
addit
antiproteina
antibodi
failur
rheumatoid
factor
protein
effect
neutral
attribut
austin
mw
respect
lowermw
prepar
protein
ie
dalton
effect
therefor
suggest
molecul
highermw
substanc
bind
infecti
virusantibodi
complex
survey
physicochein
paramet
indic
austin
daniel
net
charg
shape
irrelev
interpret
somewhat
puzzl
sinc
worker
consid
steri
hindranc
basi
neutral
seem
fewer
molecul
highermw
substanc
bind
virusantibodi
eoinplex
complex
satur
therefor
complet
steric
hinder
lowermw
compound
way
garw
hsve
report
neutral
semliki
forest
viru
guinea
pig
antiserum
enhanc
addit
serum
variou
anim
speci
natur
enhanc
factor
mode
action
character
studi
neutral
polioviru
rabbit
antiserum
mandel
observ
degre
neutral
enhanc
subsequ
addit
antiserum
rabbit
antiserum
induc
one
speci
anim
eg
goat
whole
globulin
specif
fraction
thereof
anoth
anim
eg
rabbit
design
goat
antirabbit
globulin
goat
antirabbit
fab
studi
mice
chronic
infect
ldh
viru
notkin
et
az
suspect
presenc
infecti
virusantibodi
complex
sera
mice
neutral
goat
antimous
globulin
confirm
suspicion
gener
phenomenon
extend
seen
herpesviru
could
neutral
antiglobulin
serum
ash
notkin
exposur
herpesviru
hyperimmun
rabbit
antiserum
consider
proport
viru
surviv
goat
antirabbit
globulin
neutral
gcneral
phenomenon
describ
adenoviru
kjellh
pereira
polioviru
human
stool
specimen
keller
dwyer
vaccinia
viru
majer
link
influenza
viru
majer
link
vee
viru
hahon
equin
arter
viru
radwan
burger
ndv
b
mandel
unpublish
observ
bacteriophag
goodman
donch
dudley
e
al
adler
et
al
follow
suggest
notkin
et
al
term
sensit
indic
infecti
virusantibodi
complex
neutral
sensit
viru
antiantibodi
design
mediat
neutral
notkin
et
az
compar
effect
antisera
unfraction
well
fraction
globulin
mediat
neutral
viral
antiserum
obtain
mice
chronic
infect
ldh
viru
use
sensit
rabbit
antimous
globulin
antimous
igg
capabl
induc
neutral
unlik
antiigm
inact
also
shown
fab
fragment
deriv
goat
antimous
globulin
serum
secondari
neutral
activ
albeit
weak
also
block
activ
intact
globulin
fc
fragment
howev
activ
studi
suggest
igm
either
particip
sensit
could
sensit
access
mediat
neutral
third
possibl
antivir
serum
littl
igm
inasmuch
monoval
fab
abl
mediat
neutral
mode
action
could
due
aggreg
sensit
viru
polioviru
obtain
human
stool
specimen
neutral
antihuman
iga
antihuman
igm
report
keller
dwyer
worker
suggest
viru
complex
lchain
moieti
antibodi
n
anoth
report
keller
demonstr
sensit
polioviru
revers
viru
neutral
rabbit
antiserum
reactiv
peptic
digest
sulfhydryl
reduct
presenc
fragment
antibodi
fab
complex
viru
ascertain
mediat
neutral
goat
antirabbit
globulin
keller
propos
neutral
consequ
alter
structur
configur
rather
aggreg
hampar
et
al
examin
sensit
potenti
differ
class
antibodi
appear
earli
late
rabbit
immun
herpesviru
earli
antibodi
lack
appreci
neutral
activ
although
complement
neutral
viru
goat
antirabbit
globulin
neutral
viru
late
antibodi
neutral
activ
enhanc
antiantibodi
neutral
late
viru
enhanc
antiantibodi
complement
ash
et
al
investig
possibl
sensit
mediat
neutral
use
variou
combin
antibodi
frsgment
herpesvirusspecif
fragment
deriv
hyperimmun
rabbit
antiantibodi
fragment
sheep
antirabbit
globulin
serum
virusspecif
fab
fab
fragment
neutral
survivor
shown
sensit
fc
fragment
neither
viru
sensit
intact
antibodi
class
indic
neutral
sheep
antirabbit
globulin
well
fab
fab
fragment
therefrom
viru
sensit
either
fab
effect
neutral
antiglobulin
viru
sensit
fab
antifab
moder
effect
antifab
sensit
fab
neither
antifab
antifab
effect
henc
viru
sensit
unival
antibodi
fragment
could
neutral
unival
antiantibodi
fragment
basic
similar
find
report
ldh
viru
studi
ash
et
al
shown
viru
sensit
antibodi
specif
allotyp
could
neutral
antiserum
direct
allotyp
virusspecif
antiglobulin
sera
induc
rabbit
appropri
allotyp
mediat
neutral
requir
antiantiserum
induc
rabbit
lack
one
allotyp
determin
present
virusspecif
serum
exampl
antibodi
rabbit
allotyp
sensit
mediat
neutral
antiserum
rabbit
allotyp
immun
globulin
worker
attribut
particular
signific
result
allotyp
determin
specifi
characterist
variabl
region
ie
combin
site
antibodi
molecul
shinkai
yoshino
recent
examin
sensit
capabl
antibodi
produc
variou
stage
immun
respons
fragment
deriv
antibodi
antibodi
herpesviru
elicit
rabbit
collect
week
earli
week
late
immun
antiglobulin
prepar
chromatograph
isol
normal
rabbit
globulin
immun
purifi
fraction
appropri
procedur
yield
f
ab
fab
fab
fab
fragment
test
determin
sensit
neutral
show
follow
result
earli
igg
igm
late
igm
littl
neutral
activ
unlik
late
earli
igg
sensit
activ
fraction
ie
f
ab
fab
fab
fab
ii
earli
igg
neither
neutral
sensit
late
igg
fraction
f
ab
neutral
almost
well
igg
fab
fab
neutral
nioder
could
enhanc
near
full
activ
antiantibodi
fab
neutral
weakli
sensit
moder
although
fab
deriv
earli
igg
neither
sensit
neutral
shown
react
viru
block
experi
vee
viru
show
strong
suscept
sensit
human
antiserum
hahon
goat
antihuman
globulin
specif
igg
iga
neutral
sensit
viru
igm
ineffect
decid
ineffect
real
due
absenc
igm
antihodi
associ
viru
studi
hahon
reveal
fab
fragment
antiglobulin
mediat
neutral
activ
less
effect
intact
igg
hahon
express
opinion
assay
neutral
use
specif
serum
antiglobuh
carri
quench
fluoresc
infect
cell
sensit
quench
infect
mice
majer
link
studi
kinet
neutral
vaccinia
viru
neutral
human
antivir
igg
show
slight
lag
follow
exponenti
declin
level
sheep
antihuman
globulin
includ
reaction
lag
level
elimin
filtrat
viru
exclud
aggreg
elimin
lag
tendenc
reaction
level
radwan
burger
present
data
indic
fab
region
bound
antiviru
antibodi
target
site
mediat
neutral
sensit
equin
arter
viru
cleav
bound
antibodi
trypsin
viru
complex
fragment
antibodi
insensit
neutral
complement
retain
sensit
antiglobulin
henc
evid
indic
absenc
fc
region
notkin
et
al
attribut
neutral
sensit
viru
aggreg
complex
antiglobulin
herpesviru
complex
hyperimmun
antibodi
isol
gradient
centrifug
treat
antiglobulin
compar
untreat
complex
treatment
caus
increas
sediment
rate
influenza
viru
two
discret
surfac
antigen
hemagglutinin
neuraminidas
interact
hemagglutinin
antibodi
result
neutral
unlik
reaction
neuraminidas
antibodi
studi
antigenantibodi
reaction
majer
link
show
hemagglutinin
reaction
insensit
antiglobulin
howev
addit
antiglobulin
neuraminidas
reaction
result
neutral
theoriz
site
respect
critic
noncrit
infect
neutral
via
noncrit
site
mediat
antiglobulin
could
explain
basi
steric
interfer
adjac
hemagglutinin
less
like
opinion
majer
link
antiglobulin
stabil
neuraminidaseantibodi
reaction
presum
worker
consid
stabil
could
effect
neighbor
hemagglutinin
structur
term
stabil
defin
sensit
adenoviru
neutral
antiantibodi
describ
kjellh
pereira
studi
determin
viral
antigen
induc
neutral
antibodi
guinea
pig
antibodi
hexon
antigen
adenoviru
neutral
activ
antibodi
specif
adenoviru
type
eg
react
type
without
neutral
addit
goat
antiguinea
pig
globulin
result
neutral
evid
antibodi
influenc
viral
replic
process
viral
uncoat
occur
henc
focu
interest
antibodi
function
restrict
either
direct
effect
antibodi
integr
virion
subvers
one
earli
stage
replic
cycl
indic
previous
section
e
neutral
final
manifest
sever
phenomena
fundament
differ
elementari
level
one
envis
morpholog
simpl
virion
sever
copi
singl
antigen
uniformli
distribut
throughout
capsid
low
concentr
interact
one
sever
molecul
homogen
antibodi
popul
result
lose
infecti
capabl
extrem
one
envis
morpholog
complex
viru
compos
sever
diff
went
antigen
topograph
complex
distribut
antigen
virusspecif
other
hostspecif
react
one
class
antibodi
other
differ
class
eg
herpesviru
see
miyamoto
et
al
addit
rel
concentr
viru
antibodi
adjust
appropri
secondari
interact
lead
format
larg
aggreg
may
occur
concurr
reaction
repres
critic
neutral
event
readili
isol
may
also
lead
neutral
superfici
reason
systemat
analysi
intrins
neutral
mechan
entail
examin
direct
effect
antibodi
virion
examin
distinct
earli
stage
viral
growth
cycl
shown
irrevers
damag
may
ensu
certain
virus
expos
antisera
presenc
complement
almeida
waterson
instanc
includ
rccent
studi
oroszlan
gilden
radwan
et
al
virus
envelop
analysi
interact
antigenantibodi
system
reveal
hostspecif
envelop
antigen
react
antibodi
presenc
complet
complement
system
result
format
lesion
envelop
berri
almeida
similar
result
describ
radwan
et
az
visibl
hole
leakag
intern
genom
materi
clearli
repres
irrepar
damag
howev
interact
virus
antibodi
nonenvelop
antigen
result
neutral
could
revers
radwan
et
al
shown
exposur
neutral
polioviru
acid
condit
restor
infect
mandel
mandel
similarli
acid
treatment
neutral
tobacco
mosaic
viru
result
reactiv
rappaport
subsequ
studi
mani
virus
simpl
complex
shown
revers
neutral
achiev
varieti
procedur
review
topic
see
mandel
result
indic
alter
capsid
induc
antibodi
bind
fulli
revers
report
reactiv
acid
necessarili
entail
dissoci
virusantibodi
complex
adenoviru
neutral
rabbit
antibodi
kjellh
b
although
report
certain
condit
neutral
viru
incap
adsorb
host
cell
basi
neutral
everi
case
adsorpt
neutral
viru
describ
sever
bacteri
anim
virus
hultin
mckee
nagano
oda
tolmach
rubin
franklin
mandel
dale
kajioka
joklik
silverstein
marcu
moreov
report
viru
still
suscept
neutral
adsorpt
provid
penetr
yet
occur
nagano
mutai
ishida
ackermann
mandel
mandel
yoshino
taniguchi
stinski
cunningham
observ
particularli
latter
implic
stage
replic
cycl
subsequ
adsorpt
antibodysensit
stage
capabl
neutral
polioviru
adsorb
hela
cell
found
vari
accord
sever
condit
mandel
low
multipl
antibodi
soon
virusantibodi
interact
virusantibodi
complex
adsorb
well
unneutr
viru
high
multipl
adsorpt
impair
total
negat
neutral
viru
held
c
capabl
adsorb
improv
exceed
control
threefold
timedepend
improv
seen
antibodi
first
shown
joklik
darnel
polioviru
particl
adsorb
hela
cell
low
temperatur
equal
chanc
either
penetr
elut
higher
temperatur
possibl
anybodi
might
bia
altern
favor
elut
examin
mandel
found
neutral
viru
decreas
probabl
elutionabout
compar
unneutr
viru
observ
togeth
enhanc
adsorpt
capac
impli
viru
react
antibodi
virion
acquir
greater
bind
affin
receptor
neutral
avian
infecti
bronchiti
viru
effect
elut
stinski
cunningham
ndv
silverstein
marcu
rabbit
poxviru
joklik
elut
greater
neutral
viru
sever
studi
bcen
concern
microscop
observ
fate
adsorb
neutral
viru
dale
kajioka
joklik
silverstein
marcu
penetr
occur
uncoat
process
appear
unusu
leav
impress
intracellular
particl
randomli
degrad
incomplet
uncoat
biochem
studi
polioviru
mandel
observ
fraction
cellassoci
viru
uncoat
smaller
neutral
unneutr
virusabout
compar
uncoat
unneutr
viru
viral
rna
distribut
intact
rna
degrad
ie
acidsolubl
rna
uncoat
neutral
viru
half
much
degrad
rna
seen
intact
rna
detect
basic
similar
result
describ
stinski
cunningham
quit
differ
virusavian
infecti
bronchiti
envelop
viru
sever
studi
indic
presenc
antibodi
ligand
antigen
bind
site
caus
alter
biochem
characterist
capsid
dna
coliphag
incap
infect
bacteri
protoplast
bowman
patnod
report
viru
treat
highli
dilut
antiserum
infect
demonstr
intact
bacteria
bacteri
protoplast
sinc
dnase
affect
phage
infect
could
attribut
releas
dna
howev
antidna
serum
lupu
erythematosu
neutral
infect
protoplast
worker
suggest
capsid
undergon
rearrang
render
dna
access
interact
extern
environ
kjellkn
pereira
propos
hexon
structur
adenoviru
compos
two
antigen
one
intern
interact
extern
antigen
antibodi
caus
rearrang
expos
intern
antigen
thu
enabl
react
neutral
antibodi
possibl
interpret
enhanc
infect
arbovirus
antibodi
hawk
lafferti
suggest
effect
may
attribut
particl
effect
new
protein
coat
result
bind
antibodi
studi
electrophoret
characterist
polioviru
mandel
show
capsid
structur
metast
conform
oscil
two
distinguish
isoelectr
state
neutral
irrespect
antibodi
multipl
capsid
stabil
one
conform
state
studi
topograph
arrang
structur
element
picornaviru
capsid
carri
label
procedur
shown
eg
carthew
benek
et
al
polypeptid
highli
label
rel
inaccess
appear
entir
shield
although
free
state
bind
label
compound
carthew
show
react
antibodi
polypeptid
becam
access
indic
rearrang
spatial
organ
capsid
occur
light
observ
interest
consid
result
describ
breindl
neutralis
polioviru
virusantibodi
complex
fraction
yield
fragment
consist
atibodi
bound
polypeptid
result
togeth
label
rcsult
suggest
interest
possibl
antibodi
initi
combin
reactiv
site
may
includ
polypeptid
conform
rearrang
may
ensu
allow
antibodi
transfer
allegi
compat
receptor
polypeptid
schemat
propos
rearrang
might
occur
suggest
lonbergholm
yin
vitro
system
uncoat
polioviru
develop
de
mandel
neutral
polioviru
examin
system
seen
resist
uncoat
n
previou
studi
intracellular
fate
neutral
polioviru
mandel
evid
low
level
uncoat
seen
form
degrad
viral
rna
howev
similar
result
seen
nativ
viru
unlik
neutral
viru
undegrad
rna
also
seen
degrad
rna
possibl
reflect
aberr
abort
uncoat
process
neutral
viru
well
nativ
viru
suscept
perhap
basic
problem
neutral
phenomenon
concern
mechan
wherebi
antibodi
depriv
virion
infecti
capabl
second
basic
problem
perhap
quantit
requir
antibodi
exert
effect
n
likelihood
solut
either
problem
point
solut
earli
studi
andrew
elford
burnet
et
al
began
suggest
way
think
latter
problem
studi
kinet
characterist
thc
neutral
reaction
andrew
elford
summar
find
percentag
law
n
essenc
observ
given
concentr
antiserum
neutral
fraction
viru
per
unit
time
irrespect
concentr
initi
viral
input
law
howev
qualifi
concentr
antibodi
consider
excess
concentr
viru
law
found
appli
virusantibodi
interact
gener
basi
relationship
understood
term
collis
frequenc
rel
concentr
reactant
number
success
collis
function
concentr
viru
antibodi
concentr
antibodi
great
excess
number
collis
per
unit
time
decreas
result
remov
antibodi
bind
viru
sinc
collis
indiscrimin
number
involv
unneutr
particl
diminish
proport
unit
time
result
reaction
first
order
viru
concentr
increas
number
collis
increas
accordingli
fraction
viru
particl
undergo
neutral
lower
concentr
observ
follow
rate
neutral
function
concentr
free
antibodi
rate
constant
provid
decreas
free
antibodi
concentr
cours
reaction
extrem
small
rel
total
concentr
condit
reaction
plot
semilogarithm
plot
linear
relationship
seen
kind
describ
express
firstord
reaction
howev
clear
reaction
actual
secondord
involv
two
react
molecul
indic
section
ii
e
propos
neutral
result
sequenti
bimolecular
interact
culmin
critic
number
antibodi
molecul
associ
virion
instanc
plot
logarithm
surviv
fraction
viru
function
time
linear
earli
phase
reaction
analys
neutral
reaction
dulbecco
et
al
interpret
observ
evid
singlehit
phenomenon
cri
ticism
interpret
pure
specul
ground
occasion
reaction
record
show
evid
base
timedepend
delay
neutral
multihit
reaction
eg
lafferti
philipson
accord
target
theori
inactiv
proport
surviv
viru
express
equat
v
vo
concentr
viru
time
zero
k
constant
n
number
target
per
virion
must
hit
order
virion
inactiv
case
n
equat
reduc
semilogarithm
plot
reaction
fit
eq
show
linear
cours
time
zero
indic
one
success
encount
inactiv
particl
one
success
encount
requir
period
time
elaps
allow
total
necessari
encount
first
particl
inactiv
period
time
indic
number
hit
requir
valu
n
eq
portray
graphic
period
seen
lag
shoulder
curv
preced
linear
cours
inactiv
singlehit
mechan
rule
possibl
one
molecul
combin
particl
prior
inactiv
rule
particip
molecul
inactiv
event
otherwis
particip
would
manifest
lag
time
cours
inactiv
data
rappaport
show
four
five
molecul
antibodi
per
inactiv
virion
indic
one
molecul
involv
caus
neutral
studi
yoshino
taniguchi
ash
notkin
krummel
uhr
dudley
et
al
hahon
lewentonkriss
mandel
show
sever
molecul
antibodi
react
one
virion
anim
bacteri
prior
inactiv
presenc
detect
use
antiglobulin
mediat
neutral
n
sever
studi
mediat
inactiv
show
rapid
rate
nonetheless
also
characterist
singlehit
mechan
exampl
studi
dudley
et
al
krummel
uhr
reaction
rate
mediat
reaction
threeto
fourfold
rapid
direct
reaction
suggest
earliest
bind
molecul
noneffect
could
made
effect
antiglobulin
instanc
multihit
kinet
observ
eg
lafferti
philipson
either
low
temperatur
antibodi
igm
class
sera
low
dilut
involv
conceiv
effect
interact
condit
might
requir
cooper
sever
molecul
antibodi
bind
neighbor
antigen
possibl
multihit
phenomenon
singlehit
kinet
would
requir
necessari
hit
occur
simultan
sequenti
recent
dellaporta
westaway
review
question
minimum
number
molecul
antibodi
requir
neutral
view
previous
propos
westaway
neutral
result
multihit
reaction
conclus
base
sever
phenomena
sever
exampl
multihit
inactiv
report
lag
seen
kinet
analysi
exist
infecti
virusantibodi
complex
neutral
complement
antiglobulin
report
outcom
virusantibodi
interact
variabl
depend
host
cell
indic
neutral
infecti
virusantibodi
complex
may
ensu
prolong
incub
synergist
effect
either
within
nativ
virion
compos
sever
distinct
antigen
particl
hybrid
antigen
result
mix
infect
produc
phenotyp
mix
particl
ie
capsid
specif
parent
observ
definit
knowledg
neutral
avail
illustr
well
use
fortifi
singlehit
hypothesi
outset
investig
consid
instanc
shoulder
evid
kinet
analys
support
multihit
mechan
logic
support
singlehit
mechan
shoulder
evid
argument
averag
sever
molecul
antibodi
may
combin
virion
neutral
whether
one
function
neutral
present
undetermin
possibl
one
may
function
defici
may
react
site
respond
appropri
relev
observ
made
sever
studi
neutral
infecti
virusantibodi
complex
antiglobulin
also
show
singlehit
mechan
rate
exce
rate
homotyp
reaction
viru
requir
n
hit
neutral
receiv
nz
hit
neutraliz
antiglobulin
also
pertin
monoval
fragment
antiglobulin
mediat
neutral
observ
also
explain
singlehit
basi
assum
virusantibodi
interact
may
ineffect
subject
activ
view
neutral
depend
multihit
reaction
also
express
daniel
indic
neutral
outcom
sequenti
reaction
involv
initi
free
viru
infecti
virusantibodi
complex
final
requir
molecul
react
virion
lose
infect
howev
short
full
requir
antiantibodi
could
achiev
final
effect
difficult
envis
explantori
mechan
sinc
antiantibodi
bind
virion
antivir
antibodi
essenc
number
virusbound
antibodi
increas
antiglobulin
reaction
singlehit
mechan
impli
either
one
critic
site
neutral
one
molecul
antibodi
caus
neutral
sever
site
infecti
phenotyp
mix
particl
sens
two
particl
sinc
capsid
compos
antigen
progenitor
unexpect
reaction
show
need
one
molecul
relev
excess
amount
antiserum
either
parent
littl
neutral
effect
wherea
mixtur
antisera
parent
neutral
effect
result
extens
studi
serolog
reaction
togavirus
dellaporta
westaway
propos
multihit
model
account
neutral
previous
report
westaway
neutral
requir
sever
antigenantibodi
complex
strateg
dispos
viral
surfac
sinc
virus
also
hemagglutin
sinc
neutral
absolut
hostdepend
topolog
bound
antibodi
determin
host
complex
neutral
infecti
whether
virion
retain
abil
hemagglutin
virus
contain
two
antigen
type
group
specif
extent
crossreact
occur
base
neutral
hemagglutinationinhibit
depend
crossreact
antibodi
dispos
viral
surfac
recent
hypothesi
propos
account
neutral
polioviru
suggest
mechan
wherebi
one
molecul
antibodi
achiev
end
mandel
hypothesi
assumpt
made
neutral
result
one
effect
collis
justif
assumpt
base
interpret
kinet
data
effect
collis
depend
either
reaction
critic
site
reaction
antigen
site
critic
manner
previou
studi
mandel
show
polioviru
capsid
undergo
spontan
oscil
two
conform
state
character
distinct
isoelectr
point
inactiv
antibodi
stabil
capsid
one
conform
state
subsequ
studi
mandel
highli
dilut
antiserum
show
redistribut
viral
popul
normal
neutral
conform
state
allornon
mechan
two
state
differ
ph
unit
condit
particl
intermedi
isoelectr
point
seen
moreov
proport
viru
neutral
proport
viru
conform
stabil
equal
also
shown
vitro
system
capabl
carri
earli
stage
viral
uncoat
neutral
viru
refractori
observ
integr
follow
hypothesi
metast
natur
viral
capsid
suggest
intersuhunit
cooper
transit
effect
attach
one
molecul
antibodi
antigen
subunit
stabil
subunit
specif
nonfunct
conform
cooper
transit
neighbor
unit
similarli
stabil
entir
capsid
becom
conform
homogen
expect
base
similar
structur
viral
capsid
structur
protein
subject
alloster
transit
see
monod
et
al
discuss
alloster
particl
state
incap
undergo
normal
interact
plasma
membran
suscept
cell
point
earlier
neutral
viru
retain
capabl
adsorb
increas
affin
probabl
highli
charg
natur
abnorm
conform
extens
studi
neutral
herpesviru
particular
emphasi
sensit
mediat
complement
yoshino
colleagu
propos
hypothesi
account
neutral
sensit
yoshino
isono
crucial
hypothesi
appreci
variabl
inher
antibodi
respect
class
bind
affin
accord
hypothesi
effici
antibodi
capabl
initi
seri
physicochem
chang
virion
culmin
neutral
less
effici
antibodi
induc
chang
n
case
complement
presum
antiglobulin
mediat
reaction
ineffici
antibodi
slowreact
terminolog
c
n
bind
viru
drive
reaction
stage
complement
complet
reaction
term
far
variou
antibodi
alter
virion
toward
neutral
state
worker
classifi
antibodi
slowreact
earli
igm
late
igm
earli
intermedi
igg
incap
per
se
neutral
final
late
igg
antibodi
independ
complement
also
subdivid
essenti
chang
virion
lead
neutral
respect
depend
time
earli
stage
depend
temperatur
late
stage
propos
one
molecul
antibodi
suffici
initi
reaction
whether
fail
succeed
neutral
satisfi
featur
hypothesi
allow
interpret
sever
distinct
phenomena
character
neutral
singlehit
inactiv
role
antibodi
divers
mediat
neutral
possibl
nonneutr
state
order
understand
neutral
phenomenon
trautman
stress
necess
ascertain
two
paramet
minimum
number
critic
site
requir
infect
variou
small
virusantibodi
complex
infecti
deriv
inform
trautman
develop
comput
assist
program
base
data
fmd
viru
trautman
harri
determin
least
two
three
critic
site
number
vari
accord
host
assay
system
react
igg
requir
wherea
one
react
igm
requir
infect
total
number
either
type
critic
site
yet
known
reason
summat
avail
data
led
trautman
harri
propos
fmd
viru
contain
one
uniqu
vertex
involv
infect
structur
consist
one
igm
five
ten
igg
reactiv
site
author
indic
complic
may
aris
would
requir
investig
order
deriv
valid
interpret
discuss
six
possibl
complic
smith
report
data
clearli
show
vitro
interact
virus
vaccinia
herp
homolog
antibodi
somewhat
later
sabin
unabl
demonstr
vitro
interact
question
basic
natur
antibodi
action
howev
subsequ
studi
establish
beyond
reason
doubt
viru
homolog
antibodi
combin
aspect
viral
neutral
similar
degre
unanim
mechan
yet
understood
state
uncertainti
recent
deplor
remain
undefin
dellaporta
westaway
remain
unknown
yoshino
isono
question
remain
clarifi
daniel
consider
given
known
variabl
system
ie
compon
recogn
popul
within
broad
variat
realiz
neutral
encompass
sever
distinct
phenoma
unexpect
fundament
natur
neutral
reaction
yet
elucid
burnet
eloqu
assess
situat
p
true
today
howev
abil
cope
difficulti
improv
least
technolog
daniel
summar
neutralizt
phenomenon
repres
three
pathway
satur
viral
antigen
aggreg
crosslink
multival
virion
bival
antibodi
virolysi
although
net
result
case
loss
reduct
infect
underli
mechan
may
basic
differ
virolysi
exampl
result
envelop
viru
react
antibodi
specif
envelop
protein
depend
particip
complet
complement
system
aggreg
may
reduc
number
infecti
unit
without
liter
neutral
individu
virion
satur
may
may
involv
intrins
neutral
order
understand
fundament
mechan
seem
prefer
select
paradigm
simplest
avail
systema
simpl
viru
eg
one
compos
sever
copi
one
antigen
directli
access
antibodi
react
homogen
popul
highaffin
antibodi
eg
late
igg
capabl
neutral
without
aid
accessori
substanc
interact
viru
low
concentr
minimum
multipl
antibodi
like
reveal
viru
neutral
sinc
circumst
neutral
viru
still
adsorb
cell
convers
sinc
adsorb
viru
still
neutral
implic
viral
capsid
undergon
alter
subvert
subsequ
interact
cell
natur
alter
like
understood
basi
proteinprotein
interact
clue
alreadi
describ
indic
reactant
undergon
chang
nativ
state
antibodi
interact
complement
bind
cell
react
antigen
feinstein
row
propos
antibodi
undergo
conform
rearrang
upon
bind
antigen
extens
discuss
propos
see
feinstein
et
al
sever
exampl
cite
indic
conform
degrad
chang
virion
capsid
follow
interact
antibodi
interest
wherea
earli
antibodi
react
viru
requir
mediat
late
antibodi
neutral
independ
also
shown
one
differ
earli
late
antibodi
greater
bind
affin
late
antibodi
greater
bind
affin
greater
stress
involv
disorgan
capsid
disorgan
may
revers
eg
caus
dissociqt
state
capsid
may
accept
cell
attempt
made
articl
delin
problem
mechan
intrins
neutral
singlehit
versu
multihit
requir
neutral
natur
nonneutr
sensit
state
natur
mediat
neutral
complement
antiglobulin
differ
characterist
virusantibodi
complex
accord
antibodi
type
affin
hardli
need
state
solut
problem
repres
groundwork
consider
problem
next
levelin
vivo
interact
